Mouse and human FcR effector functions
Summary Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical communi...
Saved in:
| Published in | Immunological reviews Vol. 268; no. 1; pp. 25 - 51 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
Blackwell Publishing Ltd
01.11.2015
Wiley |
| Series | Fc receptors |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Summary
Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell‐specific—‘à la carte’—FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re‐defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high‐affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. |
|---|---|
| AbstractList | Summary
Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell‐specific—‘à la carte’—FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re‐defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high‐affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell-specific-'a la carte'-FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re-defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high-affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell‐specific—‘à la carte’—FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re‐defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high‐affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community, through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell-specific--'à la carte'--FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in re-defining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high-affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. This article is part of a series of reviews covering Fc Receptors in Volume 268 of Immunological Reviews.Summary: Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors, and of the medical community , through the identification of polymorphisms and linkage to disease but also of the pharmaceutical community, through the identification of FcRs as targets for therapy or engineering of Fc domains for the generation of enhanced therapeutic antibodies. The availability of knockout mouse lines for every single mouse FcR, of multiple or cell-specific—' a la carte'—FcR knockouts and the increasing generation of hFcR transgenics enable powerful in vivo approaches for the study of mouse and human FcR biology. This review will present the landscape of the current FcR family, their effector functions and the in vivo models at hand to study them. These in vivo models were recently instrumental in redefining the properties and effector functions of FcRs that had been overlooked or discarded from previous analyses. A particular focus will be made on the (mis)concepts on the role of high-affinity IgG receptors in vivo and on results from antibody engineering to enhance or abrogate antibody effector functions mediated by FcRs. |
| Author | Jönsson, Friederike Bruhns, Pierre |
| Author_xml | – sequence: 1 givenname: Pierre surname: Bruhns fullname: Bruhns, Pierre email: bruhns@pasteur.fr organization: Unité des Anticorps en Thérapie et Pathologie, Département d'Immunologie, Institut Pasteur, Paris, France – sequence: 2 givenname: Friederike surname: Jönsson fullname: Jönsson, Friederike organization: Unité des Anticorps en Thérapie et Pathologie, Département d'Immunologie, Institut Pasteur, Paris, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26497511$$D View this record in MEDLINE/PubMed https://pasteur.hal.science/pasteur-01281740$$DView record in HAL |
| BookMark | eNqFkMlOwzAQhi0EgrIceAGUE4JDyowdLzkCohSpgIRAcLOM44hAlmI3LG-PoaU3xFzm8s0_M98mWW271hGyizDEWEdV44dIGYcVMkABkILgD6tkAAg8pSoXG2QzhGcAlIxm62SDiiyXHHFA9i-7PrjEtEXy1DemTUb2JnFl6eys80nZt3ZWdW3YJmulqYPbWfQtcjc6uz0dp5Pr84vT40lqOcS9lkHOyjwrwXElhAOFFK2xgmf5Y0alchYoICswLwAkWCYyITKKKLFACWyLpPPcJ1Prqa8a4z91Zyo9Pp7oqQkz13sNSBXKDN4w8gdzfuq7196FmW6qYF1dm9bFxzQqUJIxRP4_KqnMlVKSRvRwjlrfheBduTwFQX8b19G4_jEe2b1FbP_YuGJJ_iqOwNEceK9q9_l3kr64vPmNXEio4r8fywnjX7SQTHJ9f3WuR_L-QcKJ0Ix9AVrdles |
| CitedBy_id | crossref_primary_10_1016_j_kint_2019_12_025 crossref_primary_10_1016_j_jaci_2016_05_047 crossref_primary_10_3390_antib9040064 crossref_primary_10_1038_icb_2016_65 crossref_primary_10_1038_s41467_021_27949_3 crossref_primary_10_1007_s00223_018_0464_7 crossref_primary_10_1002_adhm_202304574 crossref_primary_10_1111_cts_12597 crossref_primary_10_1002_JLB_4A1018_391RR crossref_primary_10_1021_acs_bioconjchem_4c00212 crossref_primary_10_3389_fimmu_2024_1409333 crossref_primary_10_3389_fimmu_2019_01602 crossref_primary_10_1007_s10238_024_01362_8 crossref_primary_10_1007_s12192_021_01229_x crossref_primary_10_1016_j_jaci_2017_06_003 crossref_primary_10_3389_fimmu_2021_804244 crossref_primary_10_1016_j_jhepr_2024_101013 crossref_primary_10_1038_s41467_018_08122_9 crossref_primary_10_1097_COH_0000000000000797 crossref_primary_10_1097_COH_0000000000000554 crossref_primary_10_1126_sciimmunol_ade2798 crossref_primary_10_1097_TP_0000000000001586 crossref_primary_10_1002_bit_26496 crossref_primary_10_3390_jcm11164664 crossref_primary_10_3390_vaccines12020208 crossref_primary_10_1038_s41598_023_36532_3 crossref_primary_10_1016_j_it_2017_12_005 crossref_primary_10_1016_j_neuropharm_2020_108104 crossref_primary_10_1136_jitc_2020_002259 crossref_primary_10_1093_femspd_ftw021 crossref_primary_10_3389_fimmu_2024_1351945 crossref_primary_10_1080_19420862_2018_1433974 crossref_primary_10_1096_fj_202001085R crossref_primary_10_3390_cells8090994 crossref_primary_10_3390_biology12070931 crossref_primary_10_1038_s41467_017_00928_3 crossref_primary_10_3389_fimmu_2019_01958 crossref_primary_10_1084_jem_20200785 crossref_primary_10_1038_s41467_021_26003_6 crossref_primary_10_1111_imr_13265 crossref_primary_10_1016_j_immuni_2020_08_002 crossref_primary_10_1016_j_jaut_2017_09_002 crossref_primary_10_1016_j_ccell_2020_04_013 crossref_primary_10_1161_ATVBAHA_119_313698 crossref_primary_10_1042_BST20200602 crossref_primary_10_1016_j_ebiom_2019_03_033 crossref_primary_10_1016_j_ijbiomac_2019_06_006 crossref_primary_10_3389_fimmu_2022_972723 crossref_primary_10_3390_biomedicines5030056 crossref_primary_10_1038_s41573_019_0054_z crossref_primary_10_3389_fimmu_2016_00215 crossref_primary_10_3390_vaccines7040124 crossref_primary_10_1073_pnas_2013350118 crossref_primary_10_3389_fimmu_2022_830482 crossref_primary_10_3390_vaccines9020137 crossref_primary_10_1002_ctm2_463 crossref_primary_10_1172_JCI129697 crossref_primary_10_1182_blood_2020005571 crossref_primary_10_1182_bloodadvances_2022009423 crossref_primary_10_1007_s13402_023_00808_7 crossref_primary_10_1111_eci_12962 crossref_primary_10_1080_19420862_2018_1564510 crossref_primary_10_1182_blood_2020009497 crossref_primary_10_1016_j_jid_2022_07_019 crossref_primary_10_1016_j_vetmic_2023_109915 crossref_primary_10_1126_scitranslmed_aaf9418 crossref_primary_10_1016_j_molimm_2021_07_024 crossref_primary_10_1128_mSphere_00556_21 crossref_primary_10_1016_j_smim_2021_101479 crossref_primary_10_3390_jcm9041226 crossref_primary_10_1016_j_tibs_2020_10_005 crossref_primary_10_1038_sigtrans_2015_1 crossref_primary_10_4049_jimmunol_2100204 crossref_primary_10_3389_fimmu_2017_00780 crossref_primary_10_1038_s41467_018_05566_x crossref_primary_10_1038_s41598_022_18375_6 crossref_primary_10_3389_fimmu_2017_01751 crossref_primary_10_1038_s41598_024_61477_6 crossref_primary_10_1371_journal_pone_0300964 crossref_primary_10_1038_emi_2016_97 crossref_primary_10_1016_j_jim_2022_113380 crossref_primary_10_1136_jitc_2023_008677 crossref_primary_10_3389_fimmu_2021_612747 crossref_primary_10_3389_fonc_2022_926289 crossref_primary_10_3390_antib9030047 crossref_primary_10_1080_19420862_2023_2208697 crossref_primary_10_4049_jimmunol_1701795 crossref_primary_10_1016_j_it_2019_01_012 crossref_primary_10_1182_bloodadvances_2021006728 crossref_primary_10_1038_s41467_019_12348_6 crossref_primary_10_1111_eci_12948 crossref_primary_10_1186_s13578_024_01237_1 crossref_primary_10_1016_j_jaci_2016_06_058 crossref_primary_10_1097_QAD_0000000000002011 crossref_primary_10_1016_j_vaccine_2022_06_046 crossref_primary_10_2147_ITT_S266242 crossref_primary_10_1007_s12257_020_0181_8 crossref_primary_10_1182_blood_2019001531 crossref_primary_10_3389_fimmu_2021_672520 crossref_primary_10_1038_s41573_022_00501_8 crossref_primary_10_1080_21645515_2023_2216085 crossref_primary_10_1016_j_celrep_2022_111099 crossref_primary_10_1016_j_intimp_2023_109954 crossref_primary_10_3389_fimmu_2019_00390 crossref_primary_10_1371_journal_ppat_1010783 crossref_primary_10_1111_jfb_15246 crossref_primary_10_1080_19490976_2019_1651596 crossref_primary_10_3390_life11090870 crossref_primary_10_3389_fimmu_2020_619925 crossref_primary_10_1186_s12974_024_03100_z crossref_primary_10_1080_19420862_2017_1323159 crossref_primary_10_1016_j_xcrm_2024_101417 crossref_primary_10_1080_07388551_2019_1566206 crossref_primary_10_1038_ni_3770 crossref_primary_10_1016_j_jbiotec_2022_10_016 crossref_primary_10_1038_s41568_023_00637_8 crossref_primary_10_1016_j_phrs_2023_106996 crossref_primary_10_1038_s41586_022_04816_9 crossref_primary_10_1111_cei_13545 crossref_primary_10_1016_j_molimm_2019_04_021 crossref_primary_10_1111_imr_12527 crossref_primary_10_1021_acs_chemrev_0c01177 crossref_primary_10_3390_antib8020030 crossref_primary_10_3389_fonc_2022_1014888 crossref_primary_10_1126_sciadv_aaw1822 crossref_primary_10_1089_neu_2019_6952 crossref_primary_10_1160_TH16_02_0109 crossref_primary_10_1007_s00436_023_07810_w crossref_primary_10_3389_fimmu_2022_980291 crossref_primary_10_1177_15330338231207318 crossref_primary_10_1038_s42003_020_01296_3 crossref_primary_10_1111_imr_13170 crossref_primary_10_1155_2016_8232830 crossref_primary_10_3390_cancers14225657 crossref_primary_10_1126_sciadv_abl4363 crossref_primary_10_1038_icb_2016_121 crossref_primary_10_17352_2455_5282_000104 crossref_primary_10_3390_vaccines10071069 crossref_primary_10_1016_j_ajog_2022_04_009 crossref_primary_10_3389_fimmu_2018_02259 crossref_primary_10_1182_bloodadvances_2020002291 crossref_primary_10_4049_immunohorizons_2100105 crossref_primary_10_1016_j_bj_2023_100666 crossref_primary_10_1097_CJI_0000000000000406 crossref_primary_10_3390_pharmaceutics15102402 crossref_primary_10_1016_j_intimp_2020_106387 crossref_primary_10_1016_j_vaccine_2019_02_033 crossref_primary_10_1016_j_jaci_2017_06_021 crossref_primary_10_3390_ijms231810206 crossref_primary_10_1158_0008_5472_CAN_23_2135 crossref_primary_10_1002_ijc_31899 crossref_primary_10_1186_s12929_021_00709_7 crossref_primary_10_3389_fimmu_2017_00877 crossref_primary_10_4155_bio_2022_0085 crossref_primary_10_1128_JVI_01696_18 crossref_primary_10_1051_medsci_2020258 crossref_primary_10_1016_j_ebiom_2022_103957 crossref_primary_10_3389_fimmu_2016_00086 crossref_primary_10_3389_fimmu_2023_1278947 crossref_primary_10_1002_eji_202149766 crossref_primary_10_1126_scitranslmed_adg3540 crossref_primary_10_3389_fimmu_2019_01139 crossref_primary_10_3389_fimmu_2018_01275 crossref_primary_10_1182_blood_2020004974 crossref_primary_10_3390_cancers13102372 crossref_primary_10_3390_ijms21155259 crossref_primary_10_4049_jimmunol_1700429 crossref_primary_10_7554_eLife_32660 crossref_primary_10_1038_nrrheum_2018_38 crossref_primary_10_3390_biom13060892 crossref_primary_10_1182_blood_2017_12_822908 crossref_primary_10_1007_s00281_016_0567_z crossref_primary_10_1002_adfm_202110905 crossref_primary_10_1186_s40425_019_0772_0 crossref_primary_10_1111_1346_8138_15583 crossref_primary_10_1080_2162402X_2022_2127284 crossref_primary_10_1111_jth_14749 crossref_primary_10_3390_ijms25031941 crossref_primary_10_3390_cancers11121909 crossref_primary_10_3390_vaccines12040441 crossref_primary_10_1016_j_ymthe_2023_03_012 crossref_primary_10_1073_pnas_1720553115 crossref_primary_10_3389_fimmu_2017_00280 crossref_primary_10_1111_imm_13412 crossref_primary_10_1038_s42003_021_01851_6 crossref_primary_10_1371_journal_pcbi_1011109 crossref_primary_10_1016_j_isci_2024_109273 crossref_primary_10_1111_sji_13009 crossref_primary_10_3389_fimmu_2020_00118 crossref_primary_10_1089_mab_2019_0030 crossref_primary_10_3389_fimmu_2022_1072702 crossref_primary_10_1007_s00259_023_06250_z crossref_primary_10_1038_ni_3797 crossref_primary_10_3389_fimmu_2022_1029759 crossref_primary_10_1016_j_antiviral_2016_05_003 crossref_primary_10_1038_s41598_022_08951_1 crossref_primary_10_3389_ti_2022_10465 crossref_primary_10_3389_fimmu_2018_01217 crossref_primary_10_1016_j_immuni_2024_06_009 crossref_primary_10_1371_journal_pone_0192123 crossref_primary_10_4049_jimmunol_1700883 crossref_primary_10_1111_imr_12457 crossref_primary_10_1111_jth_13786 crossref_primary_10_1080_09537104_2020_1786043 crossref_primary_10_1186_s13223_019_0379_5 crossref_primary_10_1016_j_ymthe_2022_01_011 crossref_primary_10_1111_imr_12455 crossref_primary_10_18632_aging_204900 crossref_primary_10_3389_fimmu_2018_03191 crossref_primary_10_1002_eji_202048953 crossref_primary_10_1016_j_jaci_2022_12_004 crossref_primary_10_1016_j_celrep_2021_110114 crossref_primary_10_1002_eji_202048833 crossref_primary_10_3389_fimmu_2023_1206026 crossref_primary_10_3390_vaccines9060597 crossref_primary_10_3390_ijms21145017 crossref_primary_10_15252_emmm_202114182 crossref_primary_10_1016_j_jaci_2017_05_027 crossref_primary_10_1016_j_cell_2022_11_012 crossref_primary_10_1038_s41598_017_02823_9 crossref_primary_10_1073_pnas_2110714118 crossref_primary_10_1038_s41591_021_01579_0 crossref_primary_10_1021_acs_molpharmaceut_3c00330 crossref_primary_10_3389_fimmu_2019_00252 crossref_primary_10_3389_fimmu_2018_00958 crossref_primary_10_1007_s11882_016_0600_2 crossref_primary_10_1016_j_clim_2023_109690 crossref_primary_10_1007_s00262_023_03478_4 crossref_primary_10_1016_j_heliyon_2024_e29027 crossref_primary_10_3389_fimmu_2018_01244 crossref_primary_10_1093_jleuko_qiad080 crossref_primary_10_1111_imcb_12326 crossref_primary_10_3389_fimmu_2019_00811 crossref_primary_10_3390_ijms22179489 crossref_primary_10_1080_19420862_2023_2300155 crossref_primary_10_1038_s41577_022_00813_1 crossref_primary_10_1080_19420862_2018_1551044 crossref_primary_10_1016_j_ccell_2022_10_015 crossref_primary_10_1128_JVI_01027_20 crossref_primary_10_1016_j_xcrm_2022_100783 crossref_primary_10_3389_fimmu_2021_692157 crossref_primary_10_1038_srep30938 crossref_primary_10_1172_JCI94039 crossref_primary_10_1016_j_celrep_2021_109140 crossref_primary_10_3389_fimmu_2023_1275193 crossref_primary_10_4049_jimmunol_2101145 crossref_primary_10_1002_eji_202350454 crossref_primary_10_1182_blood_2019003646 crossref_primary_10_1111_sji_13002 crossref_primary_10_3389_fimmu_2023_1129323 crossref_primary_10_1016_j_celrep_2021_109142 crossref_primary_10_3389_fimmu_2023_1183727 crossref_primary_10_3389_fimmu_2020_603050 crossref_primary_10_1007_s12265_021_10169_x crossref_primary_10_1093_mmy_myac050 crossref_primary_10_1016_j_jaut_2016_09_009 crossref_primary_10_1002_eji_201847924 crossref_primary_10_3389_fimmu_2019_00805 crossref_primary_10_1371_journal_pone_0201832 crossref_primary_10_3390_ijms21155295 crossref_primary_10_1016_j_bbcan_2022_188762 crossref_primary_10_1016_j_isci_2023_108132 crossref_primary_10_1016_j_celrep_2021_109452 crossref_primary_10_3389_fimmu_2020_02100 crossref_primary_10_3390_ijms232213788 crossref_primary_10_3390_antib8040057 crossref_primary_10_1002_smtd_202301142 crossref_primary_10_1111_all_13635 crossref_primary_10_3390_antib13020040 crossref_primary_10_4049_jimmunol_2200234 crossref_primary_10_1038_s41467_022_32867_z crossref_primary_10_1080_19420862_2023_2254676 crossref_primary_10_3389_fphar_2023_1213726 crossref_primary_10_1016_j_molimm_2017_12_006 crossref_primary_10_1016_j_jaci_2020_10_045 crossref_primary_10_1093_intimm_dxx059 crossref_primary_10_1097_COH_0000000000000482 crossref_primary_10_3389_fimmu_2021_713704 crossref_primary_10_1007_s11095_018_2448_8 crossref_primary_10_3390_v13061037 crossref_primary_10_3389_fneur_2020_602292 crossref_primary_10_1002_eji_202250340 crossref_primary_10_1126_sciimmunol_add8005 crossref_primary_10_1126_scitranslmed_abn9243 crossref_primary_10_1016_j_molimm_2020_06_028 crossref_primary_10_1038_s41467_023_42365_5 crossref_primary_10_3390_cimb45100488 crossref_primary_10_3389_fphar_2022_924197 crossref_primary_10_1002_path_6220 crossref_primary_10_1038_s43018_023_00516_z crossref_primary_10_1128_jvi_01094_23 crossref_primary_10_3389_fimmu_2021_666813 crossref_primary_10_1016_j_jaci_2016_02_015 crossref_primary_10_1093_ilar_ily018 crossref_primary_10_1016_j_xcrm_2023_100975 crossref_primary_10_1111_imr_12372 crossref_primary_10_1186_s40364_023_00537_x crossref_primary_10_4049_jimmunol_1601246 crossref_primary_10_1038_s41598_018_21222_2 crossref_primary_10_1371_journal_pone_0167232 crossref_primary_10_1038_s41586_022_04702_4 crossref_primary_10_1126_scitranslmed_aat1479 crossref_primary_10_1042_BCJ20180139 crossref_primary_10_1016_j_celrep_2023_112326 crossref_primary_10_3389_fimmu_2022_924766 crossref_primary_10_3390_ijms241612802 crossref_primary_10_1016_j_actbio_2021_01_045 crossref_primary_10_1126_scitranslmed_ade0054 crossref_primary_10_3389_fimmu_2019_03049 crossref_primary_10_1016_j_biochi_2018_05_019 crossref_primary_10_1016_j_antiviral_2024_105893 crossref_primary_10_1111_imr_12366 crossref_primary_10_1080_21645515_2017_1290018 crossref_primary_10_1002_iid3_192 crossref_primary_10_3389_fcell_2020_00661 crossref_primary_10_3390_microorganisms11010039 crossref_primary_10_1021_acsomega_3c01547 crossref_primary_10_1016_j_chom_2018_06_016 crossref_primary_10_1038_s41598_021_89705_3 crossref_primary_10_4049_jimmunol_1601954 crossref_primary_10_1016_j_celrep_2023_112797 crossref_primary_10_1016_j_omtm_2019_12_003 crossref_primary_10_1371_journal_pone_0288351 crossref_primary_10_1371_journal_ppat_1010474 crossref_primary_10_1038_cr_2016_12 crossref_primary_10_1016_j_reval_2022_03_007 crossref_primary_10_1111_apm_13377 crossref_primary_10_3390_tropicalmed5040169 crossref_primary_10_1016_j_coviro_2021_01_001 crossref_primary_10_1371_journal_pone_0267796 crossref_primary_10_1007_s10695_024_01325_6 crossref_primary_10_1016_j_jaci_2017_09_054 crossref_primary_10_4049_jimmunol_2000961 crossref_primary_10_3389_fimmu_2020_607333 crossref_primary_10_1002_eji_202350659 crossref_primary_10_3389_fimmu_2019_00562 crossref_primary_10_1093_intimm_dxx039 crossref_primary_10_1172_jci_insight_131882 crossref_primary_10_3389_fonc_2021_786913 crossref_primary_10_1128_mBio_01667_19 crossref_primary_10_3389_fimmu_2022_932155 crossref_primary_10_1126_sciimmunol_aan5997 crossref_primary_10_7554_eLife_68311 crossref_primary_10_1080_14760584_2021_1981864 crossref_primary_10_1111_imr_12473 crossref_primary_10_3390_cells10051175 crossref_primary_10_3389_fimmu_2017_00595 crossref_primary_10_3390_ijms22168947 |
| Cites_doi | 10.1182/blood-2010-05-280115 10.1182/blood.V87.9.3593.bloodjournal8793593 10.1073/pnas.0708960105 10.1038/369753a0 10.1172/JCI72676 10.4049/jimmunol.180.7.5083 10.1182/blood.V91.7.2369 10.1073/pnas.0703354104 10.1002/1521-4141(200002)30:2<481::AID-IMMU481>3.0.CO;2-L 10.1084/jem.20021829 10.1126/science.291.5503.484 10.1182/blood.V99.3.754 10.1016/0092-8674(93)90540-7 10.4049/jimmunol.1202017 10.1084/jem.20112005 10.4049/jimmunol.1003945 10.4049/jimmunol.180.5.3329 10.4049/jimmunol.172.10.6398 10.1084/jem.189.1.187 10.1038/367183a0 10.1182/blood.V78.4.885.885 10.1002/eji.200737655 10.4049/jimmunol.162.7.4266 10.1186/1756-8722-6-1 10.4049/jimmunol.1202227 10.1371/journal.ppat.1001203 10.1016/j.immuni.2008.04.013 10.4049/jimmunol.171.2.562 10.1084/jem.191.8.1293 10.1046/j.1365-3083.2003.01220.x 10.1016/j.cell.2015.04.016 10.1038/nri2155 10.1016/S1074-7613(00)00027-3 10.4049/jimmunol.1002146 10.4049/jimmunol.178.1.480 10.1038/nbt1143 10.4049/jimmunol.166.4.2571 10.4049/jimmunol.0804182 10.1182/blood.V96.13.4254 10.1084/jem.20070360 10.1084/jem.191.11.1999 10.1084/jem.170.1.309 10.1016/S1074-7613(04)00377-2 10.4049/jimmunol.0900842 10.1111/j.1600-065X.1999.tb01372.x 10.1016/S0002-9440(10)63081-7 10.1093/emboj/17.16.4606 10.1046/j.1365-2249.1999.01026.x 10.4049/jimmunol.1003642 10.1084/jem.189.1.179 10.1084/jem.191.5.899 10.1016/j.jaci.2010.05.017 10.1182/blood-2013-11-540526 10.1016/0092-8674(94)90115-5 10.4049/jimmunol.1202250 10.1182/blood-2011-07-367334 10.1038/71908 10.1073/pnas.1203954109 10.4049/jimmunol.1201511 10.4049/jimmunol.0902752 10.1084/jem.175.5.1353 10.1038/nri2273 10.1038/ki.2015.94 10.4049/jimmunol.0903888 10.4049/jimmunol.160.1.20 10.1073/pnas.1507534112 10.1196/annals.1313.009 10.1182/blood-2013-07-515536 10.1182/blood.V93.8.2543 10.1038/379346a0 10.1128/JVI.05541-11 10.4049/jimmunol.165.10.5954 10.1073/pnas.1019037108 10.1093/intimm/dxl110 10.1007/s00109-008-0366-7 10.1182/blood-2011-08-376046 10.1038/nm1665 10.1016/j.immuni.2005.11.010 10.1073/pnas.1319502110 10.1002/eji.201242543 10.4049/jimmunol.1301430 10.1084/jem.20051900 10.1073/pnas.1014515107 10.1016/S1074-7613(00)80045-X 10.1016/S1074-7613(02)00294-7 10.1002/eji.200526291 10.1111/j.1600-065X.2009.00832.x 10.1182/blood-2012-07-442541 10.1093/intimm/dxh110 10.4049/jimmunol.169.9.5171 10.1111/j.1365-3083.2009.02338.x 10.1172/JCI24394 10.1096/fsb2fj000378com 10.1084/jem.20051951 10.1073/pnas.1935944100 10.1084/jem.191.9.1611 10.1016/j.immuni.2011.11.009 10.1038/ni.2548 10.1002/eji.1830160318 10.1111/imr.12370 10.1038/nm1416 10.1016/S1074-7613(02)00287-X 10.1172/JCI45232 10.4049/jimmunol.164.12.6113 10.1146/annurev.immunol.21.120601.141103 10.1146/annurev.iy.09.040191.002325 10.1111/j.1365-2141.2005.05571.x 10.4049/jimmunol.176.12.7489 10.4049/jimmunol.181.10.6829 10.1371/journal.ppat.0030072 10.1128/JVI.75.24.12161-12168.2001 10.4049/jimmunol.149.11.3477 10.4049/jimmunol.180.4.2669 10.1111/imr.12363 10.1111/j.1440-1746.2006.04312.x 10.4049/jimmunol.162.7.4311 10.1182/blood-2008-01-135160 10.1084/jem.20050879 10.1073/pnas.1014074107 10.1016/S0165-2478(99)00034-6 10.4049/jimmunol.157.1.189 10.1172/JCI74572 10.1146/annurev.immunol.26.021607.090232 10.1016/j.molimm.2011.05.011 10.1074/jbc.M009483200 10.4049/jimmunol.1303272 10.1002/eji.1830160716 10.1038/383263a0 10.4049/jimmunol.1102651 10.1038/nri3582 10.1016/S1074-7613(00)80494-X 10.4049/jimmunol.176.10.5833 10.1038/358337a0 10.1084/jem.20131625 10.1046/j.1365-2567.1997.00249.x 10.3389/fimmu.2014.00254 10.4049/jimmunol.159.4.1868 10.1111/j.1365-2567.2007.02588.x 10.1038/76261 10.1158/1078-0432.CCR-12-0989 10.4049/jimmunol.144.1.371 10.1016/j.immuni.2006.11.010 10.1093/intimm/dxp121 10.4049/jimmunol.168.6.2930 10.1172/JCI18838 10.1016/j.immuni.2005.05.010 10.4161/mabs.2.2.11158 10.4049/jimmunol.0801055 10.1084/jem.187.4.505 10.1084/jem.190.7.915 10.1073/pnas.1115348108 10.4049/jimmunol.164.2.1065 10.1182/blood-2011-03-342352 10.1158/1535-7163.MCT-08-0201 10.4049/jimmunol.0801665 10.1007/s002620050418 10.1084/jem.176.2.469 10.1038/nri2072 10.1158/0008-5472.CAN-05-2856 10.4049/jimmunol.164.8.4332 10.1111/j.1365-2249.2010.04210.x 10.1073/pnas.1222264110 10.1182/blood-2006-05-024539 10.1016/j.immuni.2004.05.007 10.1182/blood-2012-07-443325 10.1084/jem.20091107 10.1182/blood-2008-09-179754 10.1016/j.jaci.2009.11.017 10.1111/imr.12335 10.1016/S0002-9440(10)63543-2 10.1182/blood-2003-03-0750 10.1126/science.1535455 10.1073/pnas.0608889104 10.1126/science.1118948 10.1002/jnr.10271 10.1002/art.21344 10.1182/blood.V92.11.3997 10.1182/blood-2010-04-280214 10.1016/j.bbrc.2009.01.176 10.1182/blood.V93.12.4387 10.1038/nm.3443 10.1038/nri914 10.4049/jimmunol.161.6.3026 10.1038/nri2206 10.1002/1521-4141(2002010)32:10<2915::AID-IMMU2915>3.0.CO;2-4 10.1200/JCO.2008.19.4118 10.1016/S1074-7613(02)00275-3 10.1158/0008-5472.CAN-07-0696 10.1128/MCB.01072-06 10.1126/science.1206954 10.1182/blood-2004-03-0850 10.1073/pnas.1301918110 10.4049/jimmunol.164.8.4178 10.1073/pnas.0508123103 10.1073/pnas.0809917106 10.1172/JCI118420 10.1016/S0022-2143(97)90003-2 10.1182/blood.V98.8.2442 10.1084/jem.179.2.745 10.4049/jimmunol.1401645 10.1016/0008-8749(90)90041-O 10.1016/j.imbio.2006.05.016 10.1172/JCI36452 10.1084/jem.193.1.25 10.1016/j.imlet.2012.01.008 10.1093/intimm/dxl017 10.4049/jimmunol.157.4.1645 10.1002/eji.200939884 10.1007/BF00430917 10.1084/jem.189.2.371 10.1053/j.gastro.2007.09.024 10.1073/pnas.1012861108 10.4049/jimmunol.170.7.3528 10.1016/j.coi.2005.09.012 10.1084/jem.20061134 10.1016/j.imlet.2009.12.005 10.1093/protein/gzt022 10.1038/74704 10.4049/jimmunol.170.5.2549 10.1084/jem.178.2.661 10.1002/bies.201100093 10.1172/JCI68964 10.4049/jimmunol.174.5.3041 10.1016/S1074-7613(00)80556-7 10.1182/blood-2011-12-401133 10.1084/jem.171.4.1239 10.1016/S1074-7613(03)00080-3 10.4049/jimmunol.1003526 10.1146/annurev.immunol.15.1.203 10.1046/j.1365-3083.2002.01024.x 10.1016/j.exphem.2006.06.015 10.1111/j.1600-065X.2008.00666.x 10.4049/jimmunol.166.5.3266 10.4049/jimmunol.1200968 10.1189/jlb.0608343 10.1002/eji.201142302 10.1073/pnas.0609174104 10.1111/j.1462-5822.2006.00699.x 10.1182/blood-2005-08-3122 10.1016/j.copbio.2009.10.011 10.4049/jimmunol.180.3.1948 10.1124/dmd.106.011734 10.4049/jimmunol.177.9.6281 10.1182/blood-2012-01-380121 10.4049/jimmunol.177.1.694 10.1084/jem.20090585 10.1164/ajrccm.156.6.9701087 10.1016/j.hoc.2006.02.010 10.1016/S0896-8411(03)00034-9 10.1084/jem.183.3.1259 10.1093/intimm/dxh380 10.1038/ni.1651 10.1084/jem.189.10.1573 10.1084/jem.142.6.1520 10.4049/jimmunol.1003076 10.1073/pnas.82.22.7706 10.1146/annurev.iy.12.040194.000431 10.1016/S1074-7613(01)00109-1 10.4049/jimmunol.165.12.6738 10.1111/j.1538-7836.2008.03212.x 10.1046/j.1523-1755.1998.00108.x 10.4049/jimmunol.1003412 10.1182/blood-2013-04-497446 10.1107/S0907444908007877 10.1038/nri2762 10.1038/icb.2008.82 10.1089/scd.1.1995.4.351 10.1111/imr.12332 10.1084/jem.20110845 10.1016/j.cell.2014.08.023 10.4049/jimmunol.143.8.2595 10.1016/j.jaci.2005.08.020 10.4049/jimmunol.0804121 10.4049/jimmunol.1102744 10.1182/blood-2011-05-353102 10.1073/pnas.0801717105 10.1002/art.30141 10.1016/j.immuni.2005.09.013 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J 10.1126/science.2523561 |
| ContentType | Journal Article |
| Copyright | 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 H94 1XC |
| DOI | 10.1111/imr.12350 |
| DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts Hyper Article en Ligne (HAL) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
| DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1600-065X |
| EndPage | 51 |
| ExternalDocumentID | oai_HAL_pasteur_01281740v1 10_1111_imr_12350 26497511 IMR12350 ark_67375_WNG_F7WX70B6_3 |
| Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Institut Pasteur – fundername: European Research Council (ERC)–Seventh Framework Program funderid: ERC‐2013‐CoG 616050 – fundername: Institut National de la Santé et de la Recherche Médicale (INSERM) |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29I 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBB EBC EBD EBS EBX EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBC OBS OEB OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7N XG1 XV2 YFH YOC YUY YYP ZGI ZXP ZZTAW ~IA ~KM ~WT AETEA CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL ACYXJ CITATION 7X8 7T5 H94 1XC |
| ID | FETCH-LOGICAL-c5000-c3093f94f0e5866e08121cac6549b4278ec02013d19d0070c36466421171d1703 |
| IEDL.DBID | DR2 |
| ISSN | 0105-2896 |
| IngestDate | Tue Oct 15 15:34:47 EDT 2024 Wed Dec 04 02:55:48 EST 2024 Wed Dec 04 15:03:38 EST 2024 Fri Dec 06 05:20:32 EST 2024 Sat Sep 28 07:57:54 EDT 2024 Sat Aug 24 00:57:29 EDT 2024 Wed Oct 30 09:46:57 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | mouse models antibody-mediated therapy Fc receptor FcγR high-affinity receptor antibody-mediated disease |
| Language | English |
| License | 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. http://onlinelibrary.wiley.com/termsAndConditions#vor Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5000-c3093f94f0e5866e08121cac6549b4278ec02013d19d0070c36466421171d1703 |
| Notes | istex:ACE8381F0E8A1AD0A947CB0D5645EACF32DC8A5A ark:/67375/WNG-F7WX70B6-3 Institut National de la Santé et de la Recherche Médicale (INSERM) Institut Pasteur European Research Council (ERC)-Seventh Framework Program - No. ERC-2013-CoG 616050 ArticleID:IMR12350 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Article-1 ObjectType-Feature-2 |
| ORCID | 0000-0002-4709-8936 0000-0002-1667-8065 |
| PMID | 26497511 |
| PQID | 1727988872 |
| PQPubID | 23479 |
| PageCount | 27 |
| ParticipantIDs | hal_primary_oai_HAL_pasteur_01281740v1 proquest_miscellaneous_1808733115 proquest_miscellaneous_1727988872 crossref_primary_10_1111_imr_12350 pubmed_primary_26497511 wiley_primary_10_1111_imr_12350_IMR12350 istex_primary_ark_67375_WNG_F7WX70B6_3 |
| PublicationCentury | 2000 |
| PublicationDate | November 2015 |
| PublicationDateYYYYMMDD | 2015-11-01 |
| PublicationDate_xml | – month: 11 year: 2015 text: November 2015 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationSeriesTitle | Fc receptors |
| PublicationTitle | Immunological reviews |
| PublicationTitleAlternate | Immunol Rev |
| PublicationYear | 2015 |
| Publisher | Blackwell Publishing Ltd Wiley |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley |
| References | Quayle JA, Watson F, Bucknall RC, Edwards SW. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunology 1997;91:266-273. Zhao W, Kepley CL, Morel PA, Okumoto LM, Fukuoka Y, Schwartz LB. Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. J Immunol 2006;177:694-701. Heijnen IA, Van de Winkel JG. A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics. J Hematotherapy 1995;4:351-356. Reilly MP, et al. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA. Blood 2001;98:2442-2447. Esser-von Bieren J, et al. Antibody-mediated trapping of helminth larvae requires CD11b and Fcgamma receptor I. J Immunol 2015;194:1154-1163. Yoshida M, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 2004;20:769-783. van Vuuren AJ, et al. CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model. J Immunol 2006;176:5833-5838. McEwan WA, Mallery DL, Rhodes DA, Trowsdale J, James LC. Intracellular antibody-mediated immunity and the role of TRIM21. BioEssays 2011;33:803-809. Williams EL, et al. Immunotherapy targeting inhibitory Fcgamma receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization. J Immunol 2013;191:4130-4140. Berthelot L, et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 2012;209:793-806. Haczku A, et al. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am J Respir Crit Care Med 1997;156:1945-1955. Lazar GA, et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci USA 2006;103:4005-4010. Pinheiro da Silva F, et al. CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat Med 2007;13:1368-1374. Syed SN, et al. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol 2009;39:3343-3356. Smith P, Dilillo DJ, Bournazos S, Li F, Ravetch JV. Mouse model recapitulating human Fcgamma receptor structural and functional diversity. Proc Natl Acad Sci USA 2012;109:6181-6186. Bergtold A, Desai DD, Gavhane A, Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005;23:503-514. van Egmond M, et al. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000;6:680-685. Fossati-Jimack L, et al. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med 2000;191:1293-1302. Daëron M. Fc receptor biology. Annu Rev Immunol 1997;15:203-234. van Vugt MJ, et al. FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo. Blood 1996;87:3593-3599. Nakamura A, Nukiwa T, Takai T. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice. J Autoimmun 2003;20:227-236. King M, McDermott P, Schreiber AD. Characterization of the Fc gamma receptor on human platelets. Cell Immunol 1990;128:462-479. van Lent PL, et al. Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am J Pathol 2001;159:2309-2320. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. Fc gamma RIV: a novel FcR with distinct IgG subclass specificity. Immunity 2005;23:41-51. Kimberly RP, Ahlstrom JW, Click ME, Edberg JC. The glycosyl phosphatidylinositol-linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII. J Exp Med 1990;171:1239-1255. Mezo AR, et al. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc Natl Acad Sci USA 2008;105:2337-2342. Kim JM, Ashkenazi A. Fcgamma receptors enable anticancer action of proapoptotic and immune-modulatory antibodies. J Exp Med 2013;210:1647-1651. Davids BJ, et al. Polymeric immunoglobulin receptor in intestinal immune defense against the lumen-dwelling protozoan parasite Giardia. J Immunol 2006;177:6281-6290. Taylor SM, Reilly MP, Schreiber AD, Chien P, Tuckosh JR, McKenzie SE. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor. Blood 2000;96:4254-4260. Otten MA, et al. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J Immunol 2008;181:6829-6836. Yoshimi R, Chang TH, Wang H, Atsumi T, Morse HC 3rd, Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J Immunol 2009;182:7527-7538. Dombrowicz D, et al. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med 2001;193:25-34. Espinosa A, et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009;206:1661-1671. Yuasa T, et al. Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 1999;189:187-194. Hatzivassiliou G, et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001;14:277-289. Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci USA 2007;104:9770-9775. Baker K, et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci USA 2011;108:9927-9932. James LC, Keeble AH, Khan Z, Rhodes DA, Trowsdale J. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci USA 2007;104:6200-6205. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006;107:2346-2353. Williams EL, et al. Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcgammaRIIB (CD32B). Eur J Immunol 2012;42:2109-2120. Mostov KE. Transepithelial transport of immunoglobulins. Annu Rev Immunol 1994;12:63-84. Crow AR, et al. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP? Blood 2011;117:971-974. Macglashan D Jr. IgE and Fc{epsilon}RI regulation. Ann N Y Acad Sci 2005;1050:73-88. Chaudhury C, et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003;197:315-322. Launay P, et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000;191:1999-2009. Gounni AS, et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367:183-186. Li H, Chehade M, Liu W, Xiong H, Mayer L, Berin MC. Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology 2007;133:1905-1915. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med 2000;191:1611-1616. Minard-Colin V, et al. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood 2008;112:1205-1213. Hamano Y, Arase H, Saisho H, Saito T. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 2000;164:6113-6119. Sharp PE, et al. FcgammaRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritis. J Immunol 2013;190:340-348. Wang R, Fu Y, Zhao Q, Pan L, Zhang W. Human Fcalpha/muR and pIgR distribute differently in intestinal tissues. Biochem Biophys Res Commun 2009;381:148-152. Ben Mkaddem S, et al. Shifting FcgammaRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. J Clin Invest 2014;124:3945-3959. Tan Sardjono C, et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis Rheum 2005;52:3220-3229. Hamre R, Farstad IN, Brandtzaeg P, Morton HC. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue. Scand J Immunol 2003;57:506-516. Palaniyandi S, Tomei E, Li Z, Conrad DH, Zhu X. CD23-dependent transcytosis of IgE and immune complex across the polarized human respiratory epithelial cells. J Immunol 2011;186:3484-3496. Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996;383:263-266. Vidarsson G, et al. FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 2006;108:3573-3579. Gillis C, Gouel-Cheron A, Jonsson F, Bruhns P. Contribution of human FcgammaRs to disease 1998; 160 2004; 20 2011; 118 2009; 87 2005; 174 2011; 117 2015; 268 2002; 99 2013; 122 2010; 185 2008; 105 2010; 184 2008; 224 2013; 121 1996; 383 2006; 211 2007; 178 1998; 17 2000; 18 2000; 13 2008; 28 1992; 358 2008; 26 2008; 118 2013; 110 1996; 379 2008; 112 2010; 2 2006; 203 2010; 6 1998; 161 2011; 121 2003; 163 2001; 166 2012; 188 1990; 128 2012; 189 2009; 182 1999; 29 1992; 149 1986; 16 2003; 171 2003; 170 2010; 162 1985; 82 2007; 13 1996; 97 2000; 191 2001; 276 2002; 69 2006; 108 1989; 244 2009; 70 1992; 256 2015; 112 1994; 12 2013; 210 2009; 183 1999; 118 2006; 107 1996; 87 2001; 159 2012; 42 2006; 103 1998; 8 2013; 26 2005; 130 2002; 55 2008; 9 2008; 7 2008; 8 2007; 35 2003; 197 2007; 37 2012; 209 1997; 91 2013; 19 2014; 5 2011; 208 2013; 14 2007; 133 1993; 75 1989; 143 1999; 10 2000; 164 2001; 15 2000; 165 1975; 142 2008; 64 2009; 206 1996; 5 2001; 14 1993; 178 2007; 26 2007; 27 2011; 333 2015; 161 2006; 12 2007; 121 2010; 125 1986; 57 2010; 126 2002; 32 2006; 18 2014; 192 1991; 9 2004; 199 1994; 369 2011; 108 1994; 367 1992; 175 1992; 176 1989; 170 2010; 130 2009; 7 2008; 86 1998; 187 2008; 84 1989; 19 2002; 16 2007; 104 2010; 10 1997; 159 2012; 120 2010; 107 2006; 34 1999; 172 1997; 156 1997; 45 2003; 57 2009; 232 2006; 176 1999; 162 2009; 113 1985; 22 2013; 6 2006; 177 2014; 20 2010; 22 2006; 20 2006; 24 2010; 116 2006; 21 2015; 88 2000; 96 2004; 172 1990; 171 2011; 63 2014; 14 2007; 7 1998; 92 1998; 91 2007; 3 2013; 191 2007; 67 1994; 76 2013; 190 2014; 123 2014; 124 2007; 204 1991; 78 1999; 190 2005; 115 2005; 116 2002; 2 1999; 189 1995; 4 2014; 158 2012; 109 2015; 194 2011; 85 2014; 382 2005; 17 2003; 102 2003; 100 2003; 20 2012; 119 2003; 21 2009; 106 1994; 179 2000; 6 1996; 183 2003; 18 1990; 144 2005; 22 2005; 23 2006; 66 2001; 291 1997; 15 1999; 94 1999; 93 1998; 54 2005; 35 2001; 98 2012; 143 2004; 104 2009; 20 2005; 310 1999; 68 2011; 33 2011; 35 2005; 1050 2008; 181 2008; 180 1997; 129 2004; 113 2004; 16 2001; 193 2005; 202 2002; 168 2002; 169 2000; 30 2005; 52 2009; 381 2011; 48 1996; 157 2001; 75 2011; 186 2009; 39 e_1_2_9_79_1 e_1_2_9_254_1 e_1_2_9_10_1 e_1_2_9_56_1 e_1_2_9_239_1 e_1_2_9_277_1 e_1_2_9_33_1 e_1_2_9_216_1 e_1_2_9_71_1 e_1_2_9_231_1 e_1_2_9_107_1 e_1_2_9_122_1 e_1_2_9_145_1 e_1_2_9_168_1 e_1_2_9_18_1 e_1_2_9_183_1 e_1_2_9_160_1 e_1_2_9_265_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_83_1 e_1_2_9_204_1 e_1_2_9_227_1 e_1_2_9_6_1 e_1_2_9_119_1 e_1_2_9_60_1 e_1_2_9_242_1 e_1_2_9_280_1 e_1_2_9_111_1 e_1_2_9_134_1 e_1_2_9_157_1 e_1_2_9_195_1 e_1_2_9_172_1 e_1_2_9_232_1 e_1_2_9_255_1 e_1_2_9_72_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_95_1 e_1_2_9_217_1 e_1_2_9_278_1 e_1_2_9_270_1 e_1_2_9_129_1 e_1_2_9_144_1 e_1_2_9_167_1 e_1_2_9_106_1 Pulford K (e_1_2_9_92_1) 1986; 57 e_1_2_9_121_1 e_1_2_9_19_1 e_1_2_9_182_1 e_1_2_9_61_1 e_1_2_9_243_1 e_1_2_9_46_1 e_1_2_9_84_1 e_1_2_9_228_1 e_1_2_9_266_1 e_1_2_9_23_1 e_1_2_9_205_1 e_1_2_9_5_1 e_1_2_9_220_1 e_1_2_9_281_1 e_1_2_9_118_1 e_1_2_9_133_1 e_1_2_9_156_1 e_1_2_9_179_1 e_1_2_9_69_1 e_1_2_9_110_1 e_1_2_9_171_1 e_1_2_9_194_1 e_1_2_9_31_1 e_1_2_9_210_1 e_1_2_9_256_1 e_1_2_9_77_1 e_1_2_9_54_1 e_1_2_9_279_1 e_1_2_9_109_1 e_1_2_9_271_1 e_1_2_9_101_1 e_1_2_9_124_1 e_1_2_9_147_1 e_1_2_9_39_1 e_1_2_9_162_1 e_1_2_9_218_1 e_1_2_9_16_1 e_1_2_9_185_1 e_1_2_9_20_1 e_1_2_9_89_1 e_1_2_9_221_1 e_1_2_9_244_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_206_1 e_1_2_9_267_1 e_1_2_9_8_1 e_1_2_9_81_1 Watanabe N (e_1_2_9_233_1) 1999; 94 e_1_2_9_282_1 e_1_2_9_113_1 e_1_2_9_159_1 e_1_2_9_136_1 e_1_2_9_151_1 e_1_2_9_197_1 e_1_2_9_28_1 e_1_2_9_229_1 e_1_2_9_211_1 e_1_2_9_257_1 e_1_2_9_78_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_272_1 e_1_2_9_93_1 e_1_2_9_108_1 e_1_2_9_70_1 e_1_2_9_100_1 Mkaddem SB (e_1_2_9_94_1) 2014; 382 e_1_2_9_123_1 e_1_2_9_169_1 e_1_2_9_146_1 e_1_2_9_219_1 e_1_2_9_17_1 e_1_2_9_184_1 e_1_2_9_161_1 e_1_2_9_245_1 e_1_2_9_222_1 e_1_2_9_21_1 e_1_2_9_67_1 e_1_2_9_44_1 e_1_2_9_268_1 e_1_2_9_260_1 e_1_2_9_283_1 e_1_2_9_7_1 e_1_2_9_82_1 Hasegawa S (e_1_2_9_102_1) 1999; 93 e_1_2_9_112_1 e_1_2_9_135_1 e_1_2_9_158_1 e_1_2_9_207_1 e_1_2_9_173_1 e_1_2_9_196_1 Latour S (e_1_2_9_11_1) 1996; 157 e_1_2_9_29_1 e_1_2_9_150_1 e_1_2_9_75_1 e_1_2_9_98_1 e_1_2_9_190_1 e_1_2_9_52_1 e_1_2_9_235_1 e_1_2_9_212_1 e_1_2_9_258_1 e_1_2_9_90_1 e_1_2_9_273_1 Gosselin EJ (e_1_2_9_27_1) 1992; 149 e_1_2_9_250_1 e_1_2_9_103_1 e_1_2_9_126_1 e_1_2_9_149_1 Dombrowicz D (e_1_2_9_148_1) 1996; 157 e_1_2_9_14_1 e_1_2_9_141_1 e_1_2_9_187_1 e_1_2_9_37_1 e_1_2_9_164_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_87_1 e_1_2_9_200_1 e_1_2_9_223_1 e_1_2_9_269_1 e_1_2_9_284_1 e_1_2_9_2_1 e_1_2_9_261_1 e_1_2_9_138_1 e_1_2_9_115_1 e_1_2_9_199_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_208_1 e_1_2_9_130_1 e_1_2_9_176_1 e_1_2_9_153_1 e_1_2_9_191_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_99_1 e_1_2_9_236_1 e_1_2_9_259_1 e_1_2_9_76_1 e_1_2_9_91_1 e_1_2_9_274_1 Jankovic D (e_1_2_9_213_1) 1997; 159 e_1_2_9_251_1 Vugt MJ (e_1_2_9_174_1) 1996; 87 e_1_2_9_125_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_140_1 e_1_2_9_163_1 e_1_2_9_186_1 e_1_2_9_42_1 e_1_2_9_88_1 e_1_2_9_224_1 e_1_2_9_201_1 e_1_2_9_65_1 e_1_2_9_247_1 e_1_2_9_80_1 e_1_2_9_285_1 e_1_2_9_262_1 e_1_2_9_114_1 e_1_2_9_137_1 e_1_2_9_9_1 Capron M (e_1_2_9_104_1) 1989; 19 e_1_2_9_152_1 e_1_2_9_175_1 e_1_2_9_198_1 e_1_2_9_209_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_35_1 e_1_2_9_214_1 e_1_2_9_96_1 e_1_2_9_12_1 e_1_2_9_237_1 Metes D (e_1_2_9_120_1) 1998; 91 e_1_2_9_275_1 e_1_2_9_252_1 e_1_2_9_128_1 e_1_2_9_166_1 e_1_2_9_105_1 e_1_2_9_189_1 e_1_2_9_58_1 e_1_2_9_143_1 e_1_2_9_181_1 e_1_2_9_62_1 e_1_2_9_202_1 e_1_2_9_24_1 e_1_2_9_85_1 e_1_2_9_225_1 e_1_2_9_248_1 Repp R (e_1_2_9_155_1) 1991; 78 e_1_2_9_4_1 e_1_2_9_263_1 e_1_2_9_240_1 e_1_2_9_117_1 e_1_2_9_178_1 e_1_2_9_47_1 e_1_2_9_132_1 Hazenbos WL (e_1_2_9_234_1) 1998; 161 e_1_2_9_193_1 e_1_2_9_170_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_215_1 e_1_2_9_238_1 e_1_2_9_276_1 e_1_2_9_13_1 e_1_2_9_97_1 e_1_2_9_230_1 e_1_2_9_253_1 e_1_2_9_127_1 e_1_2_9_188_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_142_1 e_1_2_9_165_1 e_1_2_9_180_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_203_1 e_1_2_9_249_1 e_1_2_9_86_1 e_1_2_9_226_1 e_1_2_9_264_1 e_1_2_9_3_1 e_1_2_9_241_1 Kleinau S (e_1_2_9_246_1) 1999; 162 e_1_2_9_139_1 e_1_2_9_116_1 e_1_2_9_177_1 e_1_2_9_25_1 e_1_2_9_131_1 e_1_2_9_154_1 e_1_2_9_48_1 e_1_2_9_192_1 |
| References_xml | – volume: 69 start-page: 110 year: 2002 end-page: 116 article-title: Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin‐mediated calcium increase, and neurotransmitter release in motor neurons publication-title: J Neurosci Res – volume: 189 start-page: 1573 year: 1999 end-page: 1579 article-title: Modulation of immunoglobulin (Ig)E‐mediated systemic anaphylaxis by low‐affinity Fc receptors for IgG publication-title: J Exp Med – volume: 232 start-page: 59 year: 2009 end-page: 71 article-title: Inhibitory ITAMs as novel regulators of immunity publication-title: Immunol Rev – volume: 107 start-page: 19396 year: 2010 end-page: 19401 article-title: FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo publication-title: Proc Natl Acad Sci USA – volume: 30 start-page: 481 year: 2000 end-page: 490 article-title: Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex‐triggered inflammation but not in autoantibody‐induced hemolysis publication-title: Eur J Immunol – volume: 188 start-page: 1751 year: 2012 end-page: 1760 article-title: CD64 expression distinguishes monocyte‐derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization publication-title: J Immunol – volume: 183 start-page: 1259 year: 1996 end-page: 1263 article-title: Reconstitution of human Fc gamma RIII cell type specificity in transgenic mice publication-title: J Exp Med – volume: 84 start-page: 1511 year: 2008 end-page: 1520 article-title: A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody‐dependent function publication-title: J Leukoc Biol – volume: 105 start-page: 2337 year: 2008 end-page: 2342 article-title: Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn publication-title: Proc Natl Acad Sci USA – volume: 118 start-page: 3738 year: 2008 end-page: 3750 article-title: FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE‐induced lung inflammation publication-title: J Clin Invest – volume: 175 start-page: 1353 year: 1992 end-page: 1365 article-title: Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI publication-title: J Exp Med – volume: 159 start-page: 1868 year: 1997 end-page: 1875 article-title: Fc epsilonRI‐deficient mice infected with mount normal Th2‐type responses while displaying enhanced liver pathology publication-title: J Immunol – volume: 186 start-page: 3289 year: 2011 end-page: 3293 article-title: Cutting edge: intravenous Ig inhibits invariant NKT cell‐mediated allergic airway inflammation through FcgammaRIIIA‐dependent mechanisms publication-title: J Immunol – volume: 133 start-page: 1905 year: 2007 end-page: 1915 article-title: Allergen‐IgE complexes trigger CD23‐dependent CCL20 release from human intestinal epithelial cells publication-title: Gastroenterology – volume: 26 start-page: 5489 year: 2008 end-page: 5491 article-title: Evidence for linkage disequilibrium between Fcgamma RIIIa‐V158F and Fcgamma RIIa‐H131R polymorphisms in white patients, and for an Fcgamma RIIIa‐restricted influence on the response to therapeutic antibodies publication-title: J Clin Oncol – volume: 203 start-page: 789 year: 2006 end-page: 797 article-title: Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors publication-title: J Exp Med – volume: 126 start-page: 306 year: 2010 end-page: 316 article-title: Peanut‐induced intestinal allergy is mediated through a mast cell‐IgE‐FcepsilonRI‐IL‐13 pathway publication-title: J Allergy Clin Immunol – volume: 192 start-page: 5540 year: 2014 end-page: 5547 article-title: FcgammaRIIb on myeloid cells rather than on B cells protects from collagen‐induced arthritis publication-title: J Immunol – volume: 118 start-page: 1113 year: 2011 end-page: 1120 article-title: CalDAG‐GEFI deficiency protects mice in a novel model of Fcgamma RIIA‐mediated thrombosis and thrombocytopenia publication-title: Blood – volume: 67 start-page: 8882 year: 2007 end-page: 8890 article-title: Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low‐affinity activating Fcgamma receptors publication-title: Cancer Res – volume: 10 start-page: 451 year: 1999 end-page: 461 article-title: From systemic T cell self‐reactivity to organ‐specific autoimmune disease via immunoglobulins publication-title: Immunity – volume: 165 start-page: 6738 year: 2000 end-page: 6742 article-title: Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice publication-title: J Immunol – volume: 34 start-page: 1490 year: 2006 end-page: 1495 article-title: Platelet FcgammaRIIA binds and internalizes IgG‐containing complexes publication-title: Exp Hematol – volume: 103 start-page: 4005 year: 2006 end-page: 4010 article-title: Engineered antibody Fc variants with enhanced effector function publication-title: Proc Natl Acad Sci USA – volume: 6 start-page: 443 year: 2000 end-page: 446 article-title: Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets publication-title: Nat Med – volume: 107 start-page: 19985 year: 2010 end-page: 19990 article-title: Antibodies mediate intracellular immunity through tripartite motif‐containing 21 (TRIM21) publication-title: Proc Natl Acad Sci USA – volume: 17 start-page: 4606 year: 1998 end-page: 4616 article-title: SYK protein tyrosine kinase regulates Fc receptor gamma‐chain‐mediated transport to lysosomes publication-title: EMBO J – volume: 7 start-page: 2517 year: 2008 end-page: 2527 article-title: Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells publication-title: Mol Cancer Ther – volume: 110 start-page: 12397 year: 2013 end-page: 12401 article-title: Intracellular antibody receptor TRIM21 prevents fatal viral infection publication-title: Proc Natl Acad Sci USA – volume: 144 start-page: 371 year: 1990 end-page: 378 article-title: Molecular cloning and expression of the mouse high affinity Fc receptor for IgG publication-title: J Immunol – volume: 20 start-page: 227 year: 2003 end-page: 236 article-title: Deregulation of peripheral B‐cell development in enhanced severity of collagen‐induced arthritis in FcgammaRIIB‐deficient mice publication-title: J Autoimmun – volume: 369 start-page: 753 year: 1994 end-page: 756 article-title: Negative feedback regulation of IgE synthesis by murine CD23 publication-title: Nature – volume: 333 start-page: 1030 year: 2011 end-page: 1034 article-title: Inhibitory Fcgamma receptor engagement drives adjuvant and anti‐tumor activities of agonistic CD40 antibodies publication-title: Science – volume: 20 start-page: 143 year: 2014 end-page: 151 article-title: Broadly neutralizing hemagglutinin stalk‐specific antibodies require FcgammaR interactions for protection against influenza virus in vivo publication-title: Nat Med – volume: 129 start-page: 492 year: 1997 end-page: 498 article-title: Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors publication-title: J Lab Clin Med – volume: 181 start-page: 6829 year: 2008 end-page: 6836 article-title: Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV publication-title: J Immunol – volume: 244 start-page: 334 year: 1989 end-page: 337 article-title: Expression of high‐affinity binding of human immunoglobulin E by transfected cells publication-title: Science – volume: 268 start-page: 241 year: 2015 end-page: 252 article-title: The platelet Fc receptor, FccRIIa publication-title: Immunol Rev – volume: 188 start-page: 1318 year: 2012 end-page: 1324 article-title: Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles publication-title: J Immunol – volume: 172 start-page: 6398 year: 2004 end-page: 6406 article-title: Mast cells, Fc epsilon RI, and IL‐13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant publication-title: J Immunol – volume: 8 start-page: 517 year: 1998 end-page: 529 article-title: Allergy‐associated FcR beta is a molecular amplifier of IgE‐ and IgG‐mediated in vivo responses publication-title: Immunity – volume: 75 start-page: 969 year: 1993 end-page: 976 article-title: Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene publication-title: Cell – volume: 124 start-page: 3945 year: 2014 end-page: 3959 article-title: Shifting FcgammaRIIA‐ITAM from activation to inhibitory configuration ameliorates arthritis publication-title: J Clin Invest – volume: 19 start-page: 1126 year: 2013 end-page: 1138 article-title: GA201 (RG7160): a novel, humanized, glycoengineered anti‐EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab publication-title: Clin Cancer Res – volume: 168 start-page: 2930 year: 2002 end-page: 2938 article-title: Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant‐combined vaccines publication-title: J Immunol – volume: 26 start-page: 589 year: 2013 end-page: 598 article-title: Engineered antibody Fc variant with selectively enhanced FcgammaRIIb binding over both FcgammaRIIa(R131) and FcgammaRIIa(H131) publication-title: Protein Eng Des Sel – volume: 189 start-page: 371 year: 1999 end-page: 380 article-title: Fcgamma receptor‐mediated induction of dendritic cell maturation and major histocompatibility complex class I‐restricted antigen presentation after immune complex internalization publication-title: J Exp Med – volume: 16 start-page: 391 year: 2002 end-page: 402 article-title: Fc gamma RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection publication-title: Immunity – volume: 70 start-page: 553 year: 2009 end-page: 564 article-title: Structural difference in the complement activation site of human IgG1 and IgG3 publication-title: Scand J Immunol – volume: 268 start-page: 236 year: 2015 end-page: 240 article-title: The biology of the classical Fcc receptors in nonhematopoietic cells publication-title: Immunol Rev – volume: 170 start-page: 3528 year: 2003 end-page: 3533 article-title: The MHC class I‐like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG‐Fc‐coupled drugs publication-title: J Immunol – volume: 26 start-page: 513 year: 2008 end-page: 533 article-title: Anti‐inflammatory actions of intravenous immunoglobulin publication-title: Annu Rev Immunol – volume: 164 start-page: 4332 year: 2000 end-page: 4339 article-title: Expression of a functional high‐affinity IgG receptor, Fc gamma RI, on human mast cells: up‐regulation by IFN‐gamma publication-title: J Immunol – volume: 35 start-page: 3020 year: 2005 end-page: 3029 article-title: IgG Fc receptor polymorphisms and association with autoimmune disease publication-title: Eur J Immunol – volume: 182 start-page: 6517 year: 2009 end-page: 6526 article-title: Fc(epsilon)RI and FcgammaRIII/CD16 differentially regulate atopic dermatitis in mice publication-title: J Immunol – volume: 177 start-page: 6281 year: 2006 end-page: 6290 article-title: Polymeric immunoglobulin receptor in intestinal immune defense against the lumen‐dwelling protozoan parasite Giardia publication-title: J Immunol – volume: 367 start-page: 183 year: 1994 end-page: 186 article-title: High‐affinity IgE receptor on eosinophils is involved in defence against parasites publication-title: Nature – volume: 186 start-page: 1899 year: 2011 end-page: 1903 article-title: The murine high‐affinity IgG receptor Fc(gamma)RIV is sufficient for autoantibody‐induced arthritis publication-title: J Immunol – volume: 20 start-page: 769 year: 2004 end-page: 783 article-title: Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells publication-title: Immunity – volume: 52 start-page: 3220 year: 2005 end-page: 3229 article-title: Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody‐induced inflammation in Fcgamma receptor IIa‐transgenic mice publication-title: Arthritis Rheum – volume: 110 start-page: 2593 year: 2013 end-page: 2598 article-title: Involvement of Toso in activation of monocytes, macrophages, and granulocytes publication-title: Proc Natl Acad Sci USA – volume: 98 start-page: 2442 year: 2001 end-page: 2447 article-title: Heparin‐induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA publication-title: Blood – volume: 189 start-page: 2995 year: 2012 end-page: 3006 article-title: Fcgamma receptors inhibit mouse and human basophil activation publication-title: J Immunol – volume: 189 start-page: 179 year: 1999 end-page: 185 article-title: Modulation of immune complex‐induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors publication-title: J Exp Med – volume: 63 start-page: 467 year: 2011 end-page: 478 article-title: Regulation of human neutrophil Fcgamma receptor IIa by C5a receptor promotes inflammatory arthritis in mice publication-title: Arthritis Rheum – volume: 20 start-page: 685 year: 2009 end-page: 691 article-title: Optimization of Fc‐mediated effector functions of monoclonal antibodies publication-title: Curr Opin Biotechnol – volume: 13 start-page: 277 year: 2000 end-page: 285 article-title: Spontaneous autoimmune disease in Fc(gamma)RIIB‐deficient mice results from strain‐specific epistasis publication-title: Immunity – volume: 6 start-page: 680 year: 2000 end-page: 685 article-title: FcalphaRI‐positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity publication-title: Nat Med – volume: 206 start-page: 2779 year: 2009 end-page: 2793 article-title: Identity of the elusive IgM Fc receptor (FcmuR) in humans publication-title: J Exp Med – volume: 116 start-page: 1020 year: 2005 end-page: 1027 article-title: Physiologic assessment of allergic rhinitis in mice: role of the high‐affinity IgE receptor (FcepsilonRI) publication-title: J Allergy Clin Immunol – volume: 16 start-page: 1091 year: 2004 end-page: 1098 article-title: CpG oligodeoxynucleotides enhance FcgammaRI‐mediated cross presentation by dendritic cells publication-title: Int Immunol – volume: 96 start-page: 4254 year: 2000 end-page: 4260 article-title: Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor publication-title: Blood – volume: 381 start-page: 148 year: 2009 end-page: 152 article-title: Human Fcalpha/muR and pIgR distribute differently in intestinal tissues publication-title: Biochem Biophys Res Commun – volume: 124 start-page: 1187 year: 2014 end-page: 1198 article-title: Serum IgE clearance is facilitated by human FcepsilonRI internalization publication-title: J Clin Invest – volume: 191 start-page: 1293 year: 2000 end-page: 1302 article-title: Markedly different pathogenicity of four immunoglobulin G isotype‐switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low‐affinity Fcgamma receptor III publication-title: J Exp Med – volume: 33 start-page: 803 year: 2011 end-page: 809 article-title: Intracellular antibody‐mediated immunity and the role of TRIM21 publication-title: BioEssays – volume: 23 start-page: 1283 year: 2005 end-page: 1288 article-title: Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels publication-title: Nat Biotechnol – volume: 156 start-page: 1945 year: 1997 end-page: 1955 article-title: CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin publication-title: Am J Respir Crit Care Med – volume: 14 start-page: 327 year: 2013 end-page: 336 article-title: Intracellular antibody‐bound pathogens stimulate immune signaling via the Fc receptor TRIM21 publication-title: Nat Immunol – volume: 119 start-page: 2533 year: 2012 end-page: 2544 article-title: Human FcgammaRIIA induces anaphylactic and allergic reactions publication-title: Blood – volume: 128 start-page: 462 year: 1990 end-page: 479 article-title: Characterization of the Fc gamma receptor on human platelets publication-title: Cell Immunol – volume: 183 start-page: 4530 year: 2009 end-page: 4536 article-title: Antitumor IgE adjuvanticity: key role of Fc epsilon RI publication-title: J Immunol – volume: 32 start-page: 2915 year: 2002 end-page: 2922 article-title: Expression of FcgammaRIII is required for development of collagen‐induced arthritis publication-title: Eur J Immunol – volume: 194 start-page: 1154 year: 2015 end-page: 1163 article-title: Antibody‐mediated trapping of helminth larvae requires CD11b and Fcgamma receptor I publication-title: J Immunol – volume: 268 start-page: 74 year: 2015 end-page: 87 article-title: Fc receptor inside‐out signaling and possible impact on antibody therapy publication-title: Immunol Rev – volume: 180 start-page: 5083 year: 2008 end-page: 5091 article-title: Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII publication-title: J Immunol – volume: 18 start-page: 409 year: 2006 end-page: 414 article-title: The MHC class I‐related FcRn ameliorates murine Lyme arthritis publication-title: Int Immunol – volume: 22 start-page: 335 year: 1985 end-page: 348 article-title: The mouse Ly‐17 locus identifies a polymorphism of the Fc receptor publication-title: Immunogenetics – volume: 149 start-page: 3477 year: 1992 end-page: 3481 article-title: Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)‐specific immunogens publication-title: J Immunol – volume: 21 start-page: 579 year: 2003 end-page: 628 article-title: The biology of IGE and the basis of allergic disease publication-title: Annu Rev Immunol – volume: 82 start-page: 7706 year: 1985 end-page: 7710 article-title: Alleles of the Ly‐17 alloantigen define polymorphisms of the murine IgG Fc receptor publication-title: Proc Natl Acad Sci USA – volume: 22 start-page: 31 year: 2005 end-page: 42 article-title: Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM publication-title: Immunity – volume: 121 start-page: 1484 year: 2011 end-page: 1496 article-title: Mouse and human neutrophils induce anaphylaxis publication-title: J Clin Invest – volume: 104 start-page: 7169 year: 2007 end-page: 7174 article-title: Systemic lupus erythematosus‐associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria publication-title: Proc Natl Acad Sci USA – volume: 9 start-page: 1179 year: 2008 end-page: 1188 article-title: Mincle is an ITAM‐coupled activating receptor that senses damaged cells publication-title: Nat Immunol – volume: 42 start-page: 2109 year: 2012 end-page: 2120 article-title: Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcgammaRIIB (CD32B) publication-title: Eur J Immunol – volume: 177 start-page: 694 year: 2006 end-page: 701 article-title: Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin‐derived human mast cells publication-title: J Immunol – volume: 209 start-page: 793 year: 2012 end-page: 806 article-title: Transglutaminase is essential for IgA nephropathy development acting through IgA receptors publication-title: J Exp Med – volume: 93 start-page: 4387 year: 1999 end-page: 4394 article-title: Human immunoglobulin A receptor (FcalphaRI, CD89) function in transgenic mice requires both FcR gamma chain and CR3 (CD11b/CD18) publication-title: Blood – volume: 210 start-page: 1647 year: 2013 end-page: 1651 article-title: Fcgamma receptors enable anticancer action of proapoptotic and immune‐modulatory antibodies publication-title: J Exp Med – volume: 159 start-page: 2309 year: 2001 end-page: 2320 article-title: Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen‐induced arthritis publication-title: Am J Pathol – volume: 3 start-page: e72 year: 2007 article-title: The importance of human FcgammaRI in mediating protection to malaria publication-title: PLoS Pathog – volume: 48 start-page: 1818 year: 2011 end-page: 1826 article-title: Characterization of IgA and IgM binding and internalization by surface‐expressed human Fcalpha/mu receptor publication-title: Mol Immunol – volume: 176 start-page: 7489 year: 2006 end-page: 7494 article-title: Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding publication-title: J Immunol – volume: 171 start-page: 1239 year: 1990 end-page: 1255 article-title: The glycosyl phosphatidylinositol‐linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII publication-title: J Exp Med – volume: 18 start-page: 573 year: 2003 end-page: 581 article-title: Colony‐stimulating factor‐1‐dependent macrophages are responsible for IVIG protection in antibody‐induced autoimmune disease publication-title: Immunity – volume: 202 start-page: 783 year: 2005 end-page: 791 article-title: Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue‐based population of memory B cells publication-title: J Exp Med – volume: 8 start-page: 205 year: 2008 end-page: 217 article-title: IgE in allergy and asthma today publication-title: Nat Rev Immunol – volume: 121 start-page: 1858 year: 2013 end-page: 1867 article-title: Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo publication-title: Blood – volume: 68 start-page: 83 year: 1999 end-page: 87 article-title: The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis publication-title: Immunol Lett – volume: 161 start-page: 1035 year: 2015 end-page: 1045 article-title: Differential Fc‐receptor engagement drives an anti‐tumor vaccinal effect publication-title: Cell – volume: 143 start-page: 34 year: 2012 end-page: 43 article-title: Suppression of mast cell degranulation through a dual‐targeting tandem IgE‐IgG Fc domain biologic engineered to bind with high affinity to FcgammaRIIb publication-title: Immunol Lett – volume: 87 start-page: 3593 year: 1996 end-page: 3599 article-title: FcR gamma‐chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo publication-title: Blood – volume: 358 start-page: 337 year: 1992 end-page: 341 article-title: Tyrosine‐containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG publication-title: Nature – volume: 99 start-page: 754 year: 2002 end-page: 758 article-title: Therapeutic activity of humanized anti‐CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene publication-title: Blood – volume: 163 start-page: 1839 year: 2003 end-page: 1848 article-title: The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex‐mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes publication-title: Am J Pathol – volume: 180 start-page: 1948 year: 2008 end-page: 1953 article-title: Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a‐ and IgG2b‐induced autoimmune hemolytic anemia in mice publication-title: J Immunol – volume: 161 start-page: 3026 year: 1998 end-page: 3032 article-title: Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16) publication-title: J Immunol – volume: 115 start-page: 3440 year: 2005 end-page: 3450 article-title: Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases publication-title: J Clin Invest – volume: 193 start-page: 25 year: 2001 end-page: 34 article-title: Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation publication-title: J Exp Med – volume: 187 start-page: 505 year: 1998 end-page: 515 article-title: Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG‐complexed antigens publication-title: J Exp Med – volume: 160 start-page: 20 year: 1998 end-page: 23 article-title: Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity publication-title: J Immunol – volume: 162 start-page: 4311 year: 1999 end-page: 4318 article-title: The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model publication-title: J Immunol – volume: 105 start-page: 9337 year: 2008 end-page: 9342 article-title: Dependence of antibody‐mediated presentation of antigen on FcRn publication-title: Proc Natl Acad Sci USA – volume: 180 start-page: 3329 year: 2008 end-page: 3338 article-title: Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection publication-title: J Immunol – volume: 35 start-page: 932 year: 2011 end-page: 944 article-title: Monocyte subsets responsible for immunoglobulin G‐dependent effector functions in vivo publication-title: Immunity – volume: 91 start-page: 2369 year: 1998 end-page: 2380 article-title: Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene publication-title: Blood – volume: 87 start-page: 3 year: 2009 end-page: 12 article-title: Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities publication-title: Immunol Cell Biol – volume: 18 start-page: 807 year: 2006 end-page: 816 article-title: Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild‐type mice publication-title: Int Immunol – volume: 1050 start-page: 73 year: 2005 end-page: 88 article-title: IgE and Fc{epsilon}RI regulation publication-title: Ann N Y Acad Sci – volume: 20 start-page: 585 year: 2006 end-page: 612 article-title: Antitumor antibodies in the treatment of cancer: Fc receptors link opsonic antibody with cellular immunity publication-title: Hematol Oncol Clin North Am – volume: 189 start-page: 187 year: 1999 end-page: 194 article-title: Deletion of fcgamma receptor IIB renders H‐2(b) mice susceptible to collagen‐induced arthritis publication-title: J Exp Med – volume: 383 start-page: 263 year: 1996 end-page: 266 article-title: Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB publication-title: Nature – volume: 16 start-page: 157 year: 2002 end-page: 168 article-title: Arthritis critically dependent on innate immune system players publication-title: Immunity – volume: 224 start-page: 11 year: 2008 end-page: 43 article-title: Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future publication-title: Immunol Rev – volume: 55 start-page: 70 year: 2002 end-page: 81 article-title: Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis publication-title: Scand J Immunol – volume: 14 start-page: 277 year: 2001 end-page: 289 article-title: IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy publication-title: Immunity – volume: 123 start-page: 3166 year: 2014 end-page: 3174 article-title: Amplification of bacteria‐induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4 publication-title: Blood – volume: 100 start-page: 13489 year: 2003 end-page: 13494 article-title: The inhibitory potential of Fc receptor homolog 4 on memory B cells publication-title: Proc Natl Acad Sci USA – volume: 2 start-page: 181 year: 2010 end-page: 189 article-title: Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions publication-title: MAbs – volume: 26 start-page: 67 year: 2007 end-page: 78 article-title: FcgammaRIII‐dependent inhibition of interferon‐gamma responses mediates suppressive effects of intravenous immune globulin publication-title: Immunity – volume: 23 start-page: 503 year: 2005 end-page: 514 article-title: Cell surface recycling of internalized antigen permits dendritic cell priming of B cells publication-title: Immunity – volume: 5 start-page: 254 year: 2014 article-title: Contribution of human FcgammaRs to disease with evidence from human polymorphisms and transgenic animal studies publication-title: Front Immunol – volume: 75 start-page: 12161 year: 2001 end-page: 12168 article-title: Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1 publication-title: J Virol – volume: 6 start-page: e1001203 year: 2010 article-title: Fcgamma receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1 publication-title: PLoS Pathog – volume: 162 start-page: 4266 year: 1999 end-page: 4270 article-title: Importance of CD23 for collagen‐induced arthritis: delayed onset and reduced severity in CD23‐deficient mice publication-title: J Immunol – volume: 28 start-page: 833 year: 2008 end-page: 846 article-title: Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody‐mediated inflammatory diseases publication-title: Immunity – volume: 42 start-page: 2959 year: 2012 end-page: 2970 article-title: Epithelial‐microbial crosstalk in polymeric Ig receptor deficient mice publication-title: Eur J Immunol – volume: 4 start-page: 351 year: 1995 end-page: 356 article-title: A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics publication-title: J Hematotherapy – volume: 176 start-page: 469 year: 1992 end-page: 475 article-title: Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as Fc gamma RII and Fc gamma RIII publication-title: J Exp Med – volume: 180 start-page: 2669 year: 2008 end-page: 2678 article-title: Inhibitory ITAM signaling by Fc alpha RI‐FcR gamma chain controls multiple activating responses and prevents renal inflammation publication-title: J Immunol – volume: 188 start-page: 4741 year: 2012 end-page: 4745 article-title: Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG publication-title: J Immunol – volume: 117 start-page: 971 year: 2011 end-page: 974 article-title: Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP? publication-title: Blood – volume: 64 start-page: 700 year: 2008 end-page: 704 article-title: Structural characterization of a human Fc fragment engineered for lack of effector functions publication-title: Acta Crystallogr D Biol Crystallogr – volume: 123 start-page: 2854 year: 2014 end-page: 2863 article-title: Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation publication-title: Blood – volume: 108 start-page: 18406 year: 2011 end-page: 18411 article-title: Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)‐mediated IgG transport publication-title: Proc Natl Acad Sci USA – volume: 121 start-page: 1563 year: 2013 end-page: 1573 article-title: The high‐affinity human IgG receptor FcgammaRI (CD64) promotes IgG‐mediated inflammation, anaphylaxis, and antitumor immunotherapy publication-title: Blood – volume: 186 start-page: 3484 year: 2011 end-page: 3496 article-title: CD23‐dependent transcytosis of IgE and immune complex across the polarized human respiratory epithelial cells publication-title: J Immunol – volume: 18 start-page: 1759 year: 2006 end-page: 1769 article-title: Enhanced half‐life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease publication-title: Int Immunol – volume: 191 start-page: 1999 year: 2000 end-page: 2009 article-title: Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor‐Iga complexes in patients and CD89 transgenic mice publication-title: J Exp Med – volume: 9 start-page: 457 year: 1991 end-page: 492 article-title: Fc receptors publication-title: Annu Rev Immunol – volume: 104 start-page: 9770 year: 2007 end-page: 9775 article-title: Fc receptor‐like 5 inhibits B cell activation via SHP‐1 tyrosine phosphatase recruitment publication-title: Proc Natl Acad Sci USA – volume: 185 start-page: 1577 year: 2010 end-page: 1583 article-title: Anti‐CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice publication-title: J Immunol – volume: 112 start-page: 1205 year: 2008 end-page: 1213 article-title: Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV publication-title: Blood – volume: 204 start-page: 1875 year: 2007 end-page: 1889 article-title: Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2‐mediated airway inflammation publication-title: J Exp Med – volume: 93 start-page: 2543 year: 1999 end-page: 2551 article-title: Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its’ intracellular expression in human megakaryocytes publication-title: Blood – volume: 15 start-page: 203 year: 1997 end-page: 234 article-title: Fc receptor biology publication-title: Annu Rev Immunol – volume: 268 start-page: 328 year: 2015 end-page: 339 article-title: TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity publication-title: Immunol Rev – volume: 16 start-page: 815 year: 1986 end-page: 821 article-title: IgE receptors on human lymphocytes. II. Detection of cells bearing IgE receptors in unstimulated mononuclear cells by means of a monoclonal antibody publication-title: Eur J Immunol – volume: 190 start-page: 987 year: 2013 end-page: 996 article-title: Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen‐driven immune responses publication-title: J Immunol – volume: 57 start-page: 71 year: 1986 end-page: 76 article-title: A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes publication-title: Immunology – volume: 29 start-page: 2613 year: 1999 end-page: 2624 article-title: Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities publication-title: Eur J Immunol – volume: 382 start-page: 221 year: 2014 end-page: 235 article-title: IgA, IgA receptors, and their anti‐inflammatory properties publication-title: Curr Top Microbiol Immunol – volume: 12 start-page: 688 year: 2006 end-page: 692 article-title: Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells publication-title: Nat Med – volume: 125 start-page: S73 year: 2010 end-page: S80 article-title: IgE, mast cells, basophils, and eosinophils publication-title: J Allergy Clin Immunol – volume: 178 start-page: 661 year: 1993 end-page: 667 article-title: Structural features of human immunoglobulin G that determine isotype‐specific differences in complement activation publication-title: J Exp Med – volume: 170 start-page: 309 year: 1989 end-page: 314 article-title: Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon publication-title: J Exp Med – volume: 104 start-page: 1386 year: 2004 end-page: 1395 article-title: OSCAR is an FcRgamma‐associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells publication-title: Blood – volume: 18 start-page: 48 year: 2000 end-page: 51 article-title: Resolution of cutaneous inflammation after local elimination of macrophages publication-title: Nat Biotechnol – volume: 171 start-page: 562 year: 2003 end-page: 568 article-title: Fc gamma Rs modulate cytotoxicity of anti‐Fas antibodies: implications for agonistic antibody‐based therapeutics publication-title: J Immunol – volume: 178 start-page: 480 year: 2007 end-page: 488 article-title: Critical role of the Fc receptor gamma‐chain on APCs in the development of allergen‐induced airway hyperresponsiveness and inflammation publication-title: J Immunol – volume: 35 start-page: 86 year: 2007 end-page: 94 article-title: Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates publication-title: Drug Metab Dispos – volume: 166 start-page: 2571 year: 2001 end-page: 2575 article-title: Engineered antibodies with increased activity to recruit complement publication-title: J Immunol – volume: 12 start-page: 63 year: 1994 end-page: 84 article-title: Transepithelial transport of immunoglobulins publication-title: Annu Rev Immunol – volume: 169 start-page: 5171 year: 2002 end-page: 5180 article-title: Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences publication-title: J Immunol – volume: 184 start-page: 336 year: 2010 end-page: 343 article-title: Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of through different receptors publication-title: J Immunol – volume: 191 start-page: 899 year: 2000 end-page: 906 article-title: Fcgamma receptor IIB‐deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease publication-title: J Exp Med – volume: 6 start-page: 1 year: 2013 article-title: A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer publication-title: J Hematol Oncol – volume: 204 start-page: 2759 year: 2007 end-page: 2769 article-title: Induction of high‐affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia publication-title: J Exp Med – volume: 110 start-page: 19501 year: 2013 end-page: 19506 article-title: Antitumor activities of agonistic anti‐TNFR antibodies require differential FcgammaRIIB coengagement in vivo publication-title: Proc Natl Acad Sci USA – volume: 54 start-page: 1166 year: 1998 end-page: 1174 article-title: Distinct contribution of Fc receptors and angiotensin II‐dependent pathways in anti‐GBM glomerulonephritis publication-title: Kidney Int – volume: 112 start-page: 10014 year: 2015 end-page: 10019 article-title: Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21 publication-title: Proc Natl Acad Sci USA – volume: 211 start-page: 503 year: 2006 end-page: 510 article-title: Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells publication-title: Immunobiology – volume: 116 start-page: 5327 year: 2010 end-page: 5333 article-title: Cytokine‐induced immune complex binding to the high‐affinity IgG receptor, FcgammaRI, in the presence of monomeric IgG publication-title: Blood – volume: 120 start-page: 4421 year: 2012 end-page: 4431 article-title: Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo publication-title: Blood – volume: 21 start-page: 1372 year: 2006 end-page: 1380 article-title: Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium‐induced colitis publication-title: J Gastroenterol Hepatol – volume: 130 start-page: 130 year: 2005 end-page: 137 article-title: A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice publication-title: Br J Haematol – volume: 189 start-page: 4981 year: 2012 end-page: 4988 article-title: FcgammaRIIb on liver sinusoidal endothelium clears small immune complexes publication-title: J Immunol – volume: 179 start-page: 745 year: 1994 end-page: 750 article-title: Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals publication-title: J Exp Med – volume: 17 start-page: 662 year: 2005 end-page: 669 article-title: Regulation of allergy by Fc receptors publication-title: Curr Opin Immunol – volume: 191 start-page: 4130 year: 2013 end-page: 4140 article-title: Immunotherapy targeting inhibitory Fcgamma receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization publication-title: J Immunol – volume: 158 start-page: 1243 year: 2014 end-page: 1253 article-title: Broadly neutralizing anti‐HIV‐1 antibodies require Fc effector functions for in vivo activity publication-title: Cell – volume: 190 start-page: 340 year: 2013 end-page: 348 article-title: FcgammaRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritis publication-title: J Immunol – volume: 106 start-page: 11230 year: 2009 end-page: 11235 article-title: Enhanced humoral immune responses against T‐independent antigens in Fc alpha/muR‐deficient mice publication-title: Proc Natl Acad Sci USA – volume: 164 start-page: 4178 year: 2000 end-page: 4184 article-title: Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc publication-title: J Immunol – volume: 15 start-page: 940 year: 2001 end-page: 949 article-title: Human neutrophils express the high‐affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma publication-title: FASEB J – volume: 14 start-page: 94 year: 2014 end-page: 108 article-title: The function of Fcgamma receptors in dendritic cells and macrophages publication-title: Nat Rev Immunol – volume: 118 start-page: 6332 year: 2011 end-page: 6341 article-title: FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling publication-title: Blood – volume: 7 start-page: 365 year: 2007 end-page: 378 article-title: New developments in FcepsilonRI regulation, function and inhibition publication-title: Nat Rev Immunol – volume: 166 start-page: 3266 year: 2001 end-page: 3276 article-title: MHC class I‐related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells publication-title: J Immunol – volume: 66 start-page: 1261 year: 2006 end-page: 1264 article-title: The high‐affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma publication-title: Cancer Res – volume: 102 start-page: 3684 year: 2003 end-page: 3692 article-title: Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa‐associated lymphoid tissue (MALT) publication-title: Blood – volume: 186 start-page: 2699 year: 2011 end-page: 2704 article-title: Functional characteristics of the high affinity IgG receptor, FcgammaRI publication-title: J Immunol – volume: 86 start-page: 951 year: 2008 end-page: 959 article-title: Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita publication-title: J Mol Med – volume: 92 start-page: 3997 year: 1998 end-page: 4002 article-title: FcgammaRIII (CD16)‐deficient mice show IgG isotype‐dependent protection to experimental autoimmune hemolytic anemia publication-title: Blood – volume: 104 start-page: 6200 year: 2007 end-page: 6205 article-title: Structural basis for PRYSPRY‐mediated tripartite motif (TRIM) protein function publication-title: Proc Natl Acad Sci USA – volume: 113 start-page: 3716 year: 2009 end-page: 3725 article-title: Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses publication-title: Blood – volume: 57 start-page: 506 year: 2003 end-page: 516 article-title: Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue publication-title: Scand J Immunol – volume: 94 start-page: 3855 year: 1999 end-page: 3863 article-title: Mast cells induce autoantibody‐mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcgamma receptors publication-title: Blood – volume: 176 start-page: 5833 year: 2006 end-page: 5838 article-title: CD64‐directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model publication-title: J Immunol – volume: 206 start-page: 1661 year: 2009 end-page: 1671 article-title: Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL‐23‐Th17 pathway publication-title: J Exp Med – volume: 22 start-page: 149 year: 2010 end-page: 156 article-title: Identification of TOSO/FAIM3 as an Fc receptor for IgM publication-title: Int Immunol – volume: 119 start-page: 5640 year: 2012 end-page: 5649 article-title: Properties of mouse and human IgG receptors and their contribution to disease models publication-title: Blood – volume: 39 start-page: 3343 year: 2009 end-page: 3356 article-title: Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma‐LAT‐dependent generation of C5a publication-title: Eur J Immunol – volume: 276 start-page: 6591 year: 2001 end-page: 6604 article-title: High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R publication-title: J Biol Chem – volume: 108 start-page: 3573 year: 2006 end-page: 3579 article-title: FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis publication-title: Blood – volume: 164 start-page: 1065 year: 2000 end-page: 1070 article-title: A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction publication-title: J Immunol – volume: 182 start-page: 7663 year: 2009 end-page: 7671 article-title: Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates publication-title: J Immunol – volume: 97 start-page: 331 year: 1996 end-page: 338 article-title: Antigen targeting to myeloid‐specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice publication-title: J Clin Invest – volume: 113 start-page: 1328 year: 2004 end-page: 1333 article-title: The MHC class I‐like Fc receptor promotes humorally mediated autoimmune disease publication-title: J Clin Invest – volume: 189 start-page: 5513 year: 2012 end-page: 5517 article-title: Cutting edge: FcgammaRIII (CD16) and FcgammaRI (CD64) Are Responsible for Anti‐Glycoprotein 75 Monoclonal Antibody TA99 Therapy for Experimental Metastatic B16 Melanoma publication-title: J Immunol – volume: 121 start-page: 392 year: 2007 end-page: 404 article-title: Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma‐receptor IIB (CD32B) from the activating Fcgamma‐receptor IIA (CD32A): biochemical, biological and functional characterization publication-title: Immunology – volume: 379 start-page: 346 year: 1996 end-page: 349 article-title: Augmented humoral and anaphylactic responses in Fc gamma RII‐deficient mice publication-title: Nature – volume: 7 start-page: 715 year: 2007 end-page: 725 article-title: FcRn: the neonatal Fc receptor comes of age publication-title: Nat Rev Immunol – volume: 19 start-page: 3 issue: Suppl year: 1989 end-page: 8 article-title: Eosinophils: receptors and mediators in hypersensitivity publication-title: Clin Exp Allergy – volume: 182 start-page: 2542 year: 2009 end-page: 2550 article-title: Human basophils express the glycosylphosphatidylinositol‐anchored low‐affinity IgG receptor Fc{gamma}RIIIB (CD16B) publication-title: J Immunol – volume: 162 start-page: 12 year: 2010 end-page: 23 article-title: CD23/FcepsilonRII: molecular multi‐tasking publication-title: Clin Exp Immunol – volume: 85 start-page: 10572 year: 2011 end-page: 10581 article-title: A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcgamma receptors to define the role of effector functions in protection against HIV publication-title: J Virol – volume: 208 start-page: 2225 year: 2011 end-page: 2236 article-title: Critical role of the neutrophil‐associated high‐affinity receptor for IgE in the pathogenesis of experimental cerebral malaria publication-title: J Exp Med – volume: 8 start-page: 34 year: 2008 end-page: 47 article-title: Fcgamma receptors as regulators of immune responses publication-title: Nat Rev Immunol – volume: 23 start-page: 41 year: 2005 end-page: 51 article-title: Fc gamma RIV: a novel FcR with distinct IgG subclass specificity publication-title: Immunity – volume: 108 start-page: 4388 year: 2011 end-page: 4393 article-title: Transfer of IgG in the female genital tract by MHC class I‐related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection publication-title: Proc Natl Acad Sci USA – volume: 5 start-page: 181 year: 1996 end-page: 188 article-title: Impaired IgG‐dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice publication-title: Immunity – volume: 174 start-page: 3041 year: 2005 end-page: 3050 article-title: Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation publication-title: J Immunol – volume: 142 start-page: 1520 year: 1975 end-page: 1533 article-title: Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages publication-title: J Exp Med – volume: 118 start-page: 164 year: 1999 end-page: 170 article-title: Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody‐mediated cytotoxicity publication-title: Clin Exp Immunol – volume: 256 start-page: 1808 year: 1992 end-page: 1812 article-title: Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes publication-title: Science – volume: 143 start-page: 2595 year: 1989 end-page: 2601 article-title: Studies of aglycosylated chimeric mouse‐human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region publication-title: J Immunol – volume: 164 start-page: 6113 year: 2000 end-page: 6119 article-title: Immune complex and Fc receptor‐mediated augmentation of antigen presentation for in vivo Th cell responses publication-title: J Immunol – volume: 109 start-page: 6181 year: 2012 end-page: 6186 article-title: Mouse model recapitulating human Fcgamma receptor structural and functional diversity publication-title: Proc Natl Acad Sci USA – volume: 310 start-page: 1510 year: 2005 end-page: 1512 article-title: Divergent immunoglobulin g subclass activity through selective Fc receptor binding publication-title: Science – volume: 16 start-page: 306 year: 1986 end-page: 312 article-title: The receptor for IgE on blood platelets publication-title: Eur J Immunol – volume: 88 start-page: 276 year: 2015 end-page: 285 article-title: Gluten exacerbates IgA nephropathy in humanized mice through gliadin‐CD89 interaction publication-title: Kidney Int – volume: 37 start-page: 3540 year: 2007 end-page: 3550 article-title: Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor publication-title: Eur J Immunol – volume: 191 start-page: 1611 year: 2000 end-page: 1616 article-title: Induction and suppression of collagen‐induced arthritis is dependent on distinct fcgamma receptors publication-title: J Exp Med – volume: 45 start-page: 146 year: 1997 end-page: 148 article-title: Increased potency of Fc‐receptor‐targeted antigens publication-title: Cancer Immunol Immunother – volume: 108 start-page: 9927 year: 2011 end-page: 9932 article-title: Neonatal Fc receptor for IgG (FcRn) regulates cross‐presentation of IgG immune complexes by CD8‐CD11b+ dendritic cells publication-title: Proc Natl Acad Sci USA – volume: 122 start-page: 3160 year: 2013 end-page: 3164 article-title: Neutrophils mediate antibody‐induced antitumor effects in mice publication-title: Blood – volume: 7 start-page: 171 year: 2009 end-page: 181 article-title: Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice publication-title: J Thromb Haemost – volume: 199 start-page: 717 year: 2004 end-page: 723 article-title: FcgammaRIIb balances efficient pathogen clearance and the cytokine‐mediated consequences of sepsis publication-title: J Exp Med – volume: 130 start-page: 82 year: 2010 end-page: 88 article-title: Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells publication-title: Immunol Lett – volume: 186 start-page: 4223 year: 2011 end-page: 4233 article-title: Antibody‐mediated coengagement of FcgammaRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus publication-title: J Immunol – volume: 119 start-page: 3084 year: 2012 end-page: 3096 article-title: IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses publication-title: Blood – volume: 170 start-page: 2549 year: 2003 end-page: 2556 article-title: Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells publication-title: J Immunol – volume: 172 start-page: 279 year: 1999 end-page: 284 article-title: Fc receptor signaling and trafficking: a connection for antigen processing publication-title: Immunol Rev – volume: 16 start-page: 379 year: 2002 end-page: 389 article-title: FcgammaRI‐deficient mice show multiple alterations to inflammatory and immune responses publication-title: Immunity – volume: 91 start-page: 266 year: 1997 end-page: 273 article-title: Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression publication-title: Immunology – volume: 165 start-page: 5954 year: 2000 end-page: 5961 article-title: Triggering Fc alpha‐receptor I (CD89) recruits neutrophils as effector cells for CD20‐directed antibody therapy publication-title: J Immunol – volume: 24 start-page: 19 year: 2006 end-page: 28 article-title: Fcgamma receptors: old friends and new family members publication-title: Immunity – volume: 190 start-page: 915 year: 1999 end-page: 922 article-title: Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component‐deficient mice publication-title: J Exp Med – volume: 124 start-page: 725 year: 2014 end-page: 729 article-title: Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity publication-title: J Clin Invest – volume: 13 start-page: 1368 year: 2007 end-page: 1374 article-title: CD16 promotes sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation publication-title: Nat Med – volume: 157 start-page: 1645 year: 1996 end-page: 1651 article-title: Anaphylaxis mediated through a humanized high affinity IgE receptor publication-title: J Immunol – volume: 78 start-page: 885 year: 1991 end-page: 889 article-title: Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony‐stimulating factor publication-title: Blood – volume: 10 start-page: 328 year: 2010 end-page: 343 article-title: FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications publication-title: Nat Rev Immunol – volume: 203 start-page: 275 year: 2006 end-page: 280 article-title: Human antibodies induce arthritis in mice deficient in the low‐affinity inhibitory IgG receptor Fc gamma RIIB publication-title: J Exp Med – volume: 291 start-page: 484 year: 2001 end-page: 486 article-title: Anti‐inflammatory activity of IVIG mediated through the inhibitory Fc receptor publication-title: Science – volume: 197 start-page: 315 year: 2003 end-page: 322 article-title: The major histocompatibility complex‐related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan publication-title: J Exp Med – volume: 157 start-page: 189 year: 1996 end-page: 197 article-title: Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low‐affinity IgG receptor homologous to human Fc gamma RIIB1 publication-title: J Immunol – volume: 27 start-page: 5128 year: 2007 end-page: 5134 article-title: CD3 and immunoglobulin G Fc receptor regulate cerebellar functions publication-title: Mol Cell Biol – volume: 2 start-page: 773 year: 2002 end-page: 786 article-title: Regulation of mast‐cell and basophil function and survival by IgE publication-title: Nat Rev Immunol – volume: 107 start-page: 2346 year: 2006 end-page: 2353 article-title: Role of platelet surface PF4 antigenic complexes in heparin‐induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications publication-title: Blood – volume: 182 start-page: 7527 year: 2009 end-page: 7538 article-title: Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF‐kappaB‐dependent cytokine expression in fibroblasts publication-title: J Immunol – volume: 76 start-page: 519 year: 1994 end-page: 529 article-title: FcR gamma chain deletion results in pleiotrophic effector cell defects publication-title: Cell – ident: e_1_2_9_255_1 doi: 10.1182/blood-2010-05-280115 – volume: 87 start-page: 3593 year: 1996 ident: e_1_2_9_174_1 article-title: FcR gamma‐chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo publication-title: Blood doi: 10.1182/blood.V87.9.3593.bloodjournal8793593 contributor: fullname: Vugt MJ – ident: e_1_2_9_269_1 doi: 10.1073/pnas.0708960105 – ident: e_1_2_9_48_1 doi: 10.1038/369753a0 – ident: e_1_2_9_191_1 doi: 10.1172/JCI72676 – ident: e_1_2_9_65_1 doi: 10.4049/jimmunol.180.7.5083 – volume: 91 start-page: 2369 year: 1998 ident: e_1_2_9_120_1 article-title: Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene publication-title: Blood doi: 10.1182/blood.V91.7.2369 contributor: fullname: Metes D – ident: e_1_2_9_123_1 doi: 10.1073/pnas.0703354104 – ident: e_1_2_9_220_1 doi: 10.1002/1521-4141(200002)30:2<481::AID-IMMU481>3.0.CO;2-L – ident: e_1_2_9_53_1 doi: 10.1084/jem.20021829 – ident: e_1_2_9_252_1 doi: 10.1126/science.291.5503.484 – ident: e_1_2_9_145_1 doi: 10.1182/blood.V99.3.754 – ident: e_1_2_9_47_1 doi: 10.1016/0092-8674(93)90540-7 – ident: e_1_2_9_75_1 doi: 10.4049/jimmunol.1202017 – ident: e_1_2_9_168_1 doi: 10.1084/jem.20112005 – ident: e_1_2_9_119_1 doi: 10.4049/jimmunol.1003945 – ident: e_1_2_9_206_1 doi: 10.4049/jimmunol.180.5.3329 – ident: e_1_2_9_241_1 doi: 10.4049/jimmunol.172.10.6398 – ident: e_1_2_9_222_1 doi: 10.1084/jem.189.1.187 – ident: e_1_2_9_100_1 doi: 10.1038/367183a0 – volume: 78 start-page: 885 year: 1991 ident: e_1_2_9_155_1 article-title: Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony‐stimulating factor publication-title: Blood doi: 10.1182/blood.V78.4.885.885 contributor: fullname: Repp R – ident: e_1_2_9_83_1 doi: 10.1002/eji.200737655 – volume: 162 start-page: 4266 year: 1999 ident: e_1_2_9_246_1 article-title: Importance of CD23 for collagen‐induced arthritis: delayed onset and reduced severity in CD23‐deficient mice publication-title: J Immunol doi: 10.4049/jimmunol.162.7.4266 contributor: fullname: Kleinau S – ident: e_1_2_9_189_1 doi: 10.1186/1756-8722-6-1 – ident: e_1_2_9_58_1 doi: 10.4049/jimmunol.1202227 – volume: 94 start-page: 3855 year: 1999 ident: e_1_2_9_233_1 article-title: Mast cells induce autoantibody‐mediated vasculitis syndrome through tumor necrosis factor production upon triggering Fcgamma receptors publication-title: Blood contributor: fullname: Watanabe N – ident: e_1_2_9_204_1 doi: 10.1371/journal.ppat.1001203 – ident: e_1_2_9_128_1 doi: 10.1016/j.immuni.2008.04.013 – ident: e_1_2_9_230_1 doi: 10.4049/jimmunol.171.2.562 – ident: e_1_2_9_218_1 doi: 10.1084/jem.191.8.1293 – ident: e_1_2_9_93_1 doi: 10.1046/j.1365-3083.2003.01220.x – ident: e_1_2_9_190_1 doi: 10.1016/j.cell.2015.04.016 – ident: e_1_2_9_5_1 doi: 10.1038/nri2155 – ident: e_1_2_9_228_1 doi: 10.1016/S1074-7613(00)00027-3 – ident: e_1_2_9_107_1 doi: 10.4049/jimmunol.1002146 – ident: e_1_2_9_42_1 doi: 10.4049/jimmunol.178.1.480 – ident: e_1_2_9_200_1 doi: 10.1038/nbt1143 – ident: e_1_2_9_273_1 doi: 10.4049/jimmunol.166.4.2571 – ident: e_1_2_9_274_1 doi: 10.4049/jimmunol.0804182 – ident: e_1_2_9_177_1 doi: 10.1182/blood.V96.13.4254 – ident: e_1_2_9_283_1 doi: 10.1084/jem.20070360 – ident: e_1_2_9_150_1 doi: 10.1084/jem.191.11.1999 – volume: 19 start-page: 3 year: 1989 ident: e_1_2_9_104_1 article-title: Eosinophils: receptors and mediators in hypersensitivity publication-title: Clin Exp Allergy contributor: fullname: Capron M – ident: e_1_2_9_106_1 doi: 10.1084/jem.170.1.309 – ident: e_1_2_9_125_1 doi: 10.1016/S1074-7613(04)00377-2 – ident: e_1_2_9_171_1 doi: 10.4049/jimmunol.0900842 – ident: e_1_2_9_23_1 doi: 10.1111/j.1600-065X.1999.tb01372.x – ident: e_1_2_9_217_1 doi: 10.1016/S0002-9440(10)63081-7 – ident: e_1_2_9_30_1 doi: 10.1093/emboj/17.16.4606 – ident: e_1_2_9_86_1 doi: 10.1046/j.1365-2249.1999.01026.x – ident: e_1_2_9_35_1 doi: 10.4049/jimmunol.1003642 – ident: e_1_2_9_221_1 doi: 10.1084/jem.189.1.179 – ident: e_1_2_9_226_1 doi: 10.1084/jem.191.5.899 – ident: e_1_2_9_242_1 doi: 10.1016/j.jaci.2010.05.017 – ident: e_1_2_9_183_1 doi: 10.1182/blood-2013-11-540526 – ident: e_1_2_9_46_1 doi: 10.1016/0092-8674(94)90115-5 – ident: e_1_2_9_71_1 doi: 10.4049/jimmunol.1202250 – ident: e_1_2_9_114_1 doi: 10.1182/blood-2011-07-367334 – ident: e_1_2_9_264_1 doi: 10.1038/71908 – ident: e_1_2_9_64_1 doi: 10.1073/pnas.1203954109 – ident: e_1_2_9_67_1 doi: 10.4049/jimmunol.1201511 – ident: e_1_2_9_282_1 doi: 10.4049/jimmunol.0902752 – ident: e_1_2_9_101_1 doi: 10.1084/jem.175.5.1353 – ident: e_1_2_9_139_1 doi: 10.1038/nri2273 – ident: e_1_2_9_169_1 doi: 10.1038/ki.2015.94 – ident: e_1_2_9_181_1 doi: 10.4049/jimmunol.0903888 – ident: e_1_2_9_281_1 doi: 10.4049/jimmunol.160.1.20 – ident: e_1_2_9_130_1 doi: 10.1073/pnas.1507534112 – ident: e_1_2_9_138_1 doi: 10.1196/annals.1313.009 – ident: e_1_2_9_182_1 doi: 10.1182/blood-2013-07-515536 – volume: 93 start-page: 2543 year: 1999 ident: e_1_2_9_102_1 article-title: Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its’ intracellular expression in human megakaryocytes publication-title: Blood doi: 10.1182/blood.V93.8.2543 contributor: fullname: Hasegawa S – ident: e_1_2_9_49_1 doi: 10.1038/379346a0 – ident: e_1_2_9_271_1 doi: 10.1128/JVI.05541-11 – ident: e_1_2_9_165_1 doi: 10.4049/jimmunol.165.10.5954 – ident: e_1_2_9_70_1 doi: 10.1073/pnas.1019037108 – ident: e_1_2_9_163_1 doi: 10.1093/intimm/dxl110 – ident: e_1_2_9_240_1 doi: 10.1007/s00109-008-0366-7 – ident: e_1_2_9_33_1 doi: 10.1182/blood-2011-08-376046 – ident: e_1_2_9_209_1 doi: 10.1038/nm1665 – ident: e_1_2_9_43_1 doi: 10.1016/j.immuni.2005.11.010 – ident: e_1_2_9_187_1 doi: 10.1073/pnas.1319502110 – ident: e_1_2_9_247_1 doi: 10.1002/eji.201242543 – ident: e_1_2_9_74_1 doi: 10.4049/jimmunol.1301430 – ident: e_1_2_9_253_1 doi: 10.1084/jem.20051900 – ident: e_1_2_9_52_1 doi: 10.1073/pnas.1014515107 – ident: e_1_2_9_66_1 doi: 10.1016/S1074-7613(00)80045-X – ident: e_1_2_9_39_1 doi: 10.1016/S1074-7613(02)00294-7 – ident: e_1_2_9_10_1 doi: 10.1002/eji.200526291 – ident: e_1_2_9_14_1 doi: 10.1111/j.1600-065X.2009.00832.x – ident: e_1_2_9_142_1 doi: 10.1182/blood-2012-07-442541 – ident: e_1_2_9_111_1 doi: 10.1093/intimm/dxh110 – ident: e_1_2_9_133_1 doi: 10.4049/jimmunol.169.9.5171 – ident: e_1_2_9_199_1 doi: 10.1111/j.1365-3083.2009.02338.x – ident: e_1_2_9_239_1 doi: 10.1172/JCI24394 – ident: e_1_2_9_285_1 doi: 10.1096/fsb2fj000378com – ident: e_1_2_9_227_1 doi: 10.1084/jem.20051951 – ident: e_1_2_9_124_1 doi: 10.1073/pnas.1935944100 – ident: e_1_2_9_223_1 doi: 10.1084/jem.191.9.1611 – ident: e_1_2_9_40_1 doi: 10.1016/j.immuni.2011.11.009 – ident: e_1_2_9_21_1 doi: 10.1038/ni.2548 – ident: e_1_2_9_103_1 doi: 10.1002/eji.1830160318 – ident: e_1_2_9_157_1 doi: 10.1111/imr.12370 – ident: e_1_2_9_256_1 doi: 10.1038/nm1416 – ident: e_1_2_9_38_1 doi: 10.1016/S1074-7613(02)00287-X – ident: e_1_2_9_61_1 doi: 10.1172/JCI45232 – ident: e_1_2_9_25_1 doi: 10.4049/jimmunol.164.12.6113 – ident: e_1_2_9_137_1 doi: 10.1146/annurev.immunol.21.120601.141103 – ident: e_1_2_9_112_1 doi: 10.1146/annurev.iy.09.040191.002325 – ident: e_1_2_9_266_1 doi: 10.1111/j.1365-2141.2005.05571.x – ident: e_1_2_9_135_1 doi: 10.4049/jimmunol.176.12.7489 – ident: e_1_2_9_249_1 doi: 10.4049/jimmunol.181.10.6829 – ident: e_1_2_9_173_1 doi: 10.1371/journal.ppat.0030072 – ident: e_1_2_9_203_1 doi: 10.1128/JVI.75.24.12161-12168.2001 – volume: 149 start-page: 3477 year: 1992 ident: e_1_2_9_27_1 article-title: Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)‐specific immunogens publication-title: J Immunol doi: 10.4049/jimmunol.149.11.3477 contributor: fullname: Gosselin EJ – ident: e_1_2_9_167_1 doi: 10.4049/jimmunol.180.4.2669 – ident: e_1_2_9_7_1 doi: 10.1111/imr.12363 – ident: e_1_2_9_248_1 doi: 10.1111/j.1440-1746.2006.04312.x – ident: e_1_2_9_151_1 doi: 10.4049/jimmunol.162.7.4311 – ident: e_1_2_9_250_1 doi: 10.1182/blood-2008-01-135160 – ident: e_1_2_9_89_1 doi: 10.1084/jem.20050879 – ident: e_1_2_9_19_1 doi: 10.1073/pnas.1014074107 – ident: e_1_2_9_154_1 doi: 10.1016/S0165-2478(99)00034-6 – volume: 157 start-page: 189 year: 1996 ident: e_1_2_9_11_1 article-title: Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low‐affinity IgG receptor homologous to human Fc gamma RIIB1 publication-title: J Immunol doi: 10.4049/jimmunol.157.1.189 contributor: fullname: Latour S – ident: e_1_2_9_126_1 doi: 10.1172/JCI74572 – ident: e_1_2_9_254_1 doi: 10.1146/annurev.immunol.26.021607.090232 – ident: e_1_2_9_85_1 doi: 10.1016/j.molimm.2011.05.011 – ident: e_1_2_9_132_1 doi: 10.1074/jbc.M009483200 – ident: e_1_2_9_72_1 doi: 10.4049/jimmunol.1303272 – ident: e_1_2_9_105_1 doi: 10.1002/eji.1830160716 – ident: e_1_2_9_16_1 doi: 10.1038/383263a0 – ident: e_1_2_9_78_1 doi: 10.4049/jimmunol.1102651 – ident: e_1_2_9_31_1 doi: 10.1038/nri3582 – ident: e_1_2_9_50_1 doi: 10.1016/S1074-7613(00)80494-X – ident: e_1_2_9_265_1 doi: 10.4049/jimmunol.176.10.5833 – ident: e_1_2_9_26_1 doi: 10.1038/358337a0 – ident: e_1_2_9_188_1 doi: 10.1084/jem.20131625 – ident: e_1_2_9_110_1 doi: 10.1046/j.1365-2567.1997.00249.x – ident: e_1_2_9_147_1 doi: 10.3389/fimmu.2014.00254 – volume: 159 start-page: 1868 year: 1997 ident: e_1_2_9_213_1 article-title: Fc epsilonRI‐deficient mice infected with Schistosoma mansoni mount normal Th2‐type responses while displaying enhanced liver pathology publication-title: J Immunol doi: 10.4049/jimmunol.159.4.1868 contributor: fullname: Jankovic D – ident: e_1_2_9_117_1 doi: 10.1111/j.1365-2567.2007.02588.x – ident: e_1_2_9_164_1 doi: 10.1038/76261 – ident: e_1_2_9_160_1 doi: 10.1158/1078-0432.CCR-12-0989 – ident: e_1_2_9_131_1 doi: 10.4049/jimmunol.144.1.371 – ident: e_1_2_9_257_1 doi: 10.1016/j.immuni.2006.11.010 – ident: e_1_2_9_96_1 doi: 10.1093/intimm/dxp121 – ident: e_1_2_9_261_1 doi: 10.4049/jimmunol.168.6.2930 – ident: e_1_2_9_238_1 doi: 10.1172/JCI18838 – ident: e_1_2_9_41_1 doi: 10.1016/j.immuni.2005.05.010 – ident: e_1_2_9_201_1 doi: 10.4161/mabs.2.2.11158 – ident: e_1_2_9_236_1 doi: 10.4049/jimmunol.0801055 – ident: e_1_2_9_29_1 doi: 10.1084/jem.187.4.505 – ident: e_1_2_9_56_1 doi: 10.1084/jem.190.7.915 – ident: e_1_2_9_259_1 doi: 10.1073/pnas.1115348108 – ident: e_1_2_9_216_1 doi: 10.4049/jimmunol.164.2.1065 – ident: e_1_2_9_268_1 doi: 10.1182/blood-2011-03-342352 – ident: e_1_2_9_270_1 doi: 10.1158/1535-7163.MCT-08-0201 – ident: e_1_2_9_121_1 doi: 10.4049/jimmunol.0801665 – ident: e_1_2_9_262_1 doi: 10.1007/s002620050418 – ident: e_1_2_9_3_1 doi: 10.1084/jem.176.2.469 – ident: e_1_2_9_141_1 doi: 10.1038/nri2072 – ident: e_1_2_9_196_1 doi: 10.1158/0008-5472.CAN-05-2856 – ident: e_1_2_9_113_1 doi: 10.4049/jimmunol.164.8.4332 – ident: e_1_2_9_109_1 doi: 10.1111/j.1365-2249.2010.04210.x – ident: e_1_2_9_57_1 doi: 10.1073/pnas.1222264110 – ident: e_1_2_9_82_1 doi: 10.1182/blood-2006-05-024539 – ident: e_1_2_9_80_1 doi: 10.1016/j.immuni.2004.05.007 – ident: e_1_2_9_186_1 doi: 10.1182/blood-2012-07-443325 – ident: e_1_2_9_95_1 doi: 10.1084/jem.20091107 – ident: e_1_2_9_136_1 doi: 10.1182/blood-2008-09-179754 – ident: e_1_2_9_140_1 doi: 10.1016/j.jaci.2009.11.017 – ident: e_1_2_9_34_1 doi: 10.1111/imr.12335 – ident: e_1_2_9_225_1 doi: 10.1016/S0002-9440(10)63543-2 – ident: e_1_2_9_88_1 doi: 10.1182/blood-2003-03-0750 – ident: e_1_2_9_15_1 doi: 10.1126/science.1535455 – ident: e_1_2_9_207_1 doi: 10.1073/pnas.0608889104 – ident: e_1_2_9_134_1 doi: 10.1126/science.1118948 – ident: e_1_2_9_90_1 doi: 10.1002/jnr.10271 – ident: e_1_2_9_156_1 doi: 10.1002/art.21344 – ident: e_1_2_9_235_1 doi: 10.1182/blood.V92.11.3997 – ident: e_1_2_9_44_1 doi: 10.1182/blood-2010-04-280214 – ident: e_1_2_9_84_1 doi: 10.1016/j.bbrc.2009.01.176 – ident: e_1_2_9_149_1 doi: 10.1182/blood.V93.12.4387 – ident: e_1_2_9_192_1 doi: 10.1038/nm.3443 – ident: e_1_2_9_32_1 doi: 10.1038/nri914 – volume: 161 start-page: 3026 year: 1998 ident: e_1_2_9_234_1 article-title: Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16) publication-title: J Immunol doi: 10.4049/jimmunol.161.6.3026 contributor: fullname: Hazenbos WL – ident: e_1_2_9_13_1 doi: 10.1038/nri2206 – ident: e_1_2_9_232_1 doi: 10.1002/1521-4141(2002010)32:10<2915::AID-IMMU2915>3.0.CO;2-4 – ident: e_1_2_9_146_1 doi: 10.1200/JCO.2008.19.4118 – ident: e_1_2_9_76_1 doi: 10.1016/S1074-7613(02)00275-3 – ident: e_1_2_9_278_1 doi: 10.1158/0008-5472.CAN-07-0696 – ident: e_1_2_9_91_1 doi: 10.1128/MCB.01072-06 – volume: 57 start-page: 71 year: 1986 ident: e_1_2_9_92_1 article-title: A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes publication-title: Immunology contributor: fullname: Pulford K – ident: e_1_2_9_152_1 doi: 10.1126/science.1206954 – ident: e_1_2_9_63_1 doi: 10.1182/blood-2004-03-0850 – ident: e_1_2_9_211_1 doi: 10.1073/pnas.1301918110 – ident: e_1_2_9_202_1 doi: 10.4049/jimmunol.164.8.4178 – ident: e_1_2_9_277_1 doi: 10.1073/pnas.0508123103 – ident: e_1_2_9_59_1 doi: 10.1073/pnas.0809917106 – ident: e_1_2_9_28_1 doi: 10.1172/JCI118420 – ident: e_1_2_9_129_1 doi: 10.1016/S0022-2143(97)90003-2 – ident: e_1_2_9_178_1 doi: 10.1182/blood.V98.8.2442 – ident: e_1_2_9_99_1 doi: 10.1084/jem.179.2.745 – ident: e_1_2_9_205_1 doi: 10.4049/jimmunol.1401645 – ident: e_1_2_9_116_1 doi: 10.1016/0008-8749(90)90041-O – ident: e_1_2_9_166_1 doi: 10.1016/j.imbio.2006.05.016 – ident: e_1_2_9_4_1 doi: 10.1172/JCI36452 – ident: e_1_2_9_244_1 doi: 10.1084/jem.193.1.25 – ident: e_1_2_9_162_1 doi: 10.1016/j.imlet.2012.01.008 – ident: e_1_2_9_214_1 doi: 10.1093/intimm/dxl017 – volume: 157 start-page: 1645 year: 1996 ident: e_1_2_9_148_1 article-title: Anaphylaxis mediated through a humanized high affinity IgE receptor publication-title: J Immunol doi: 10.4049/jimmunol.157.4.1645 contributor: fullname: Dombrowicz D – ident: e_1_2_9_60_1 doi: 10.1002/eji.200939884 – ident: e_1_2_9_9_1 doi: 10.1007/BF00430917 – volume: 382 start-page: 221 year: 2014 ident: e_1_2_9_94_1 article-title: IgA, IgA receptors, and their anti‐inflammatory properties publication-title: Curr Top Microbiol Immunol contributor: fullname: Mkaddem SB – ident: e_1_2_9_24_1 doi: 10.1084/jem.189.2.371 – ident: e_1_2_9_108_1 doi: 10.1053/j.gastro.2007.09.024 – ident: e_1_2_9_260_1 doi: 10.1073/pnas.1012861108 – ident: e_1_2_9_158_1 doi: 10.4049/jimmunol.170.7.3528 – ident: e_1_2_9_22_1 doi: 10.1016/j.coi.2005.09.012 – ident: e_1_2_9_237_1 doi: 10.1084/jem.20061134 – ident: e_1_2_9_267_1 doi: 10.1016/j.imlet.2009.12.005 – ident: e_1_2_9_280_1 doi: 10.1093/protein/gzt022 – ident: e_1_2_9_251_1 doi: 10.1038/74704 – ident: e_1_2_9_36_1 doi: 10.4049/jimmunol.170.5.2549 – ident: e_1_2_9_143_1 doi: 10.1084/jem.178.2.661 – ident: e_1_2_9_20_1 doi: 10.1002/bies.201100093 – ident: e_1_2_9_170_1 doi: 10.1172/JCI68964 – ident: e_1_2_9_219_1 doi: 10.4049/jimmunol.174.5.3041 – ident: e_1_2_9_98_1 doi: 10.1016/S1074-7613(00)80556-7 – ident: e_1_2_9_185_1 doi: 10.1182/blood-2011-12-401133 – ident: e_1_2_9_127_1 doi: 10.1084/jem.171.4.1239 – ident: e_1_2_9_77_1 doi: 10.1016/S1074-7613(03)00080-3 – ident: e_1_2_9_197_1 doi: 10.4049/jimmunol.1003526 – ident: e_1_2_9_12_1 doi: 10.1146/annurev.immunol.15.1.203 – ident: e_1_2_9_231_1 doi: 10.1046/j.1365-3083.2002.01024.x – ident: e_1_2_9_176_1 doi: 10.1016/j.exphem.2006.06.015 – ident: e_1_2_9_17_1 doi: 10.1111/j.1600-065X.2008.00666.x – ident: e_1_2_9_81_1 doi: 10.4049/jimmunol.166.5.3266 – ident: e_1_2_9_118_1 doi: 10.4049/jimmunol.1200968 – ident: e_1_2_9_284_1 doi: 10.1189/jlb.0608343 – ident: e_1_2_9_73_1 doi: 10.1002/eji.201142302 – ident: e_1_2_9_6_1 doi: 10.1073/pnas.0609174104 – ident: e_1_2_9_208_1 doi: 10.1111/j.1462-5822.2006.00699.x – ident: e_1_2_9_179_1 doi: 10.1182/blood-2005-08-3122 – ident: e_1_2_9_198_1 doi: 10.1016/j.copbio.2009.10.011 – ident: e_1_2_9_195_1 doi: 10.4049/jimmunol.180.3.1948 – ident: e_1_2_9_279_1 doi: 10.1124/dmd.106.011734 – ident: e_1_2_9_215_1 doi: 10.4049/jimmunol.177.9.6281 – ident: e_1_2_9_2_1 doi: 10.1182/blood-2012-01-380121 – ident: e_1_2_9_115_1 doi: 10.4049/jimmunol.177.1.694 – ident: e_1_2_9_55_1 doi: 10.1084/jem.20090585 – ident: e_1_2_9_245_1 doi: 10.1164/ajrccm.156.6.9701087 – ident: e_1_2_9_144_1 doi: 10.1016/j.hoc.2006.02.010 – ident: e_1_2_9_224_1 doi: 10.1016/S0896-8411(03)00034-9 – ident: e_1_2_9_153_1 doi: 10.1084/jem.183.3.1259 – ident: e_1_2_9_210_1 doi: 10.1093/intimm/dxh380 – ident: e_1_2_9_62_1 doi: 10.1038/ni.1651 – ident: e_1_2_9_51_1 doi: 10.1084/jem.189.10.1573 – ident: e_1_2_9_194_1 doi: 10.1084/jem.142.6.1520 – ident: e_1_2_9_258_1 doi: 10.4049/jimmunol.1003076 – ident: e_1_2_9_8_1 doi: 10.1073/pnas.82.22.7706 – ident: e_1_2_9_79_1 doi: 10.1146/annurev.iy.12.040194.000431 – ident: e_1_2_9_87_1 doi: 10.1016/S1074-7613(01)00109-1 – ident: e_1_2_9_263_1 doi: 10.4049/jimmunol.165.12.6738 – ident: e_1_2_9_180_1 doi: 10.1111/j.1538-7836.2008.03212.x – ident: e_1_2_9_229_1 doi: 10.1046/j.1523-1755.1998.00108.x – ident: e_1_2_9_161_1 doi: 10.4049/jimmunol.1003412 – ident: e_1_2_9_159_1 doi: 10.1182/blood-2013-04-497446 – ident: e_1_2_9_276_1 doi: 10.1107/S0907444908007877 – ident: e_1_2_9_18_1 doi: 10.1038/nri2762 – ident: e_1_2_9_175_1 doi: 10.1038/icb.2008.82 – ident: e_1_2_9_172_1 doi: 10.1089/scd.1.1995.4.351 – ident: e_1_2_9_45_1 doi: 10.1111/imr.12332 – ident: e_1_2_9_212_1 doi: 10.1084/jem.20110845 – ident: e_1_2_9_193_1 doi: 10.1016/j.cell.2014.08.023 – ident: e_1_2_9_272_1 doi: 10.4049/jimmunol.143.8.2595 – ident: e_1_2_9_243_1 doi: 10.1016/j.jaci.2005.08.020 – ident: e_1_2_9_54_1 doi: 10.4049/jimmunol.0804121 – ident: e_1_2_9_37_1 doi: 10.4049/jimmunol.1102744 – ident: e_1_2_9_122_1 doi: 10.1182/blood-2011-05-353102 – ident: e_1_2_9_68_1 doi: 10.1073/pnas.0801717105 – ident: e_1_2_9_184_1 doi: 10.1002/art.30141 – ident: e_1_2_9_69_1 doi: 10.1016/j.immuni.2005.09.013 – ident: e_1_2_9_275_1 doi: 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J – ident: e_1_2_9_97_1 doi: 10.1126/science.2523561 |
| SSID | ssj0017324 |
| Score | 2.661101 |
| SecondaryResourceType | review_article |
| Snippet | Summary
Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel... Mouse and human FcRs have been a major focus of attention not only of the scientific community, through the cloning and characterization of novel receptors,... This article is part of a series of reviews covering Fc Receptors in Volume 268 of Immunological Reviews.Summary: Mouse and human FcRs have been a major focus... |
| SourceID | hal proquest crossref pubmed wiley istex |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 25 |
| SubjectTerms | Animals Animals, Genetically Modified antibody-mediated disease antibody-mediated therapy Fc receptor FcγR high-affinity receptor Humans Immunoglobulin G - immunology Immunoglobulin G - metabolism Immunology Life Sciences Mice Mice, Knockout mouse models Mutation Protein Binding Receptors, Fc - chemistry Receptors, Fc - genetics Receptors, Fc - metabolism Receptors, IgG - genetics Receptors, IgG - metabolism |
| Title | Mouse and human FcR effector functions |
| URI | https://api.istex.fr/ark:/67375/WNG-F7WX70B6-3/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fimr.12350 https://www.ncbi.nlm.nih.gov/pubmed/26497511 https://search.proquest.com/docview/1727988872 https://search.proquest.com/docview/1808733115 https://pasteur.hal.science/pasteur-01281740 |
| Volume | 268 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB_8QPClrR-1qVWiiPiSI8km2YQ--XU9xfPhULwHYdlsNijSnMS70vrXd2b3ElRUSt8CmZDszOzOb7KzvwHYwXVRE2-dx4pSeVFQ5J6UsvSIDsovIwwYjM4798-T3mV0OoyHM_C9OQtj-SHaH240M8x6TRNc5g9PJvntz7pDBz0pXw8Yp3K-o0FLHRVwFlpebz_2MKlIpqxCVMXTPvksFs3eUCXkPCn392tw8zl6NeGn-xGumw-3VSd3nck476jHF5yO_zmyT_BhCkvdfetHSzCjq2VYsI0q_6zAbn80edCurArXNPVzu2rg2lKQUe1SbDTuuwqX3eOLw5437bDgKWqE4CnaBy2zqPR1nCaJRnwQBkqqBLPGnJpwaIVwEs0VZAURAymWEB09Jo08KNCY7DPMVaNKfwE3j0rNU6ZYiiCwlHGq8ywJc3RUPy50KB3YbnQt7i2RhmgSEBywMAN2YBet0N4n6uve_pm4l2iUSS3Mth-P_F8BChpDtaKyvqMSNR6Lq_Mfosuvhtw_SARzYKuxpMCJQ7shstKoM0HILcP8n4fvyKR-Sk0tg9iBNesG7RsRSWYc4aoDe8aYb49KnPQH5uLrv4uuwyIqPranHr_B3Lie6A2EP-N80_j5X_F4-jk |
| link.rule.ids | 230,314,780,784,885,1375,27924,27925,46294,46718 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6liapyKdAWasrDIBT14sjvh8QlPEICSQ5RouZSrdbrtaiiOpFJEPDrO7MbWwTRCvVmyWPZuzOz-4135huAt7guSuKts7wsF5bvZKnFOc8tooOycx83DI_qnUfjsD_zv8yDeQPeVbUwmh-i_uFGnqHWa3Jw-iH9h5dfXZcdqvTEgL2F7u5QQtfHSU0e5USeq5m97cDCsCLc8gpRHk_96M5utPeNciFbNL0__wU4d_Gr2oB6D-Gy-nSdd7LobNZpR_z-i9XxvmN7BIdbZGp2tSk9hoYsjmBf96r8dQzt0XLzXZq8yEzV18_siYmps0GWpUnbo7LgE5j1Pk0_9K1tkwVLUC8ES9BRaJ74uS2DOAwlQgTXEVyEGDim1IdDCkSUqDEnyYgbSHghMdJj3Bg5GerTewLNYlnIUzBTP5dR7AkvRhyY8yCWaRK6KdqqHWTS5Qa8qSabrTSXBqtiEBwwUwM2oI1qqO8T-3W_O2QrjlrZlEyd_EW-_cNBQaWpWpSXC8pSiwJ2Mf7MetHFPLLfh8wz4HWlSoa-QwcivJA4Z4zAWxLjMuveIRPbMfW1dAIDnmo7qN-IYDKJELEacK60efuo2GA0URfP_l_0FRz0p6MhGw7GX8_gASoh0EWQz6G5LjfyBaKhdfpSGf0NsaH-Wg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB_8oOKL_VRTW41FpC858rlJ6JOtjWf1jnIo3oOwbDYbFDF3xLvS-td3ZvcSqlQR3wKZkOzOzO5vsjO_AdjBdVERb50TFKV0Qq_IHSFE6RAdlFuGuGEEVO_c67PuafhjGA3n4EtTC2P4IdofbuQZer0mBx8X5T9Ofnldd6jQE-P1xZD5KRHn7w9a7igvDnxD7O1GDkYVbEYrRGk87aN3NqP5C0qFXKTZ_f0_vHkXvur9J3sJ582Xm7STq850knfk7T1Sx2cO7RWszHCpvWcM6TXMqeoNvDCdKv-8hd3eaHqjbFEVtu7qZ2dyYJtckFFt0-ao7fcdnGbfT751nVmLBUdSJwRH0kFomYalq6KEMYUAwfekkAzDxpy6cCiJeBL15aUFMQPJgBEfPUaNsVegNoNVWKhGlVoHOw9LFSeBDBJEgaWIEpWnzM_RUt2oUL6w4FMz13xsmDR4E4HggLkesAW7qIX2PnFfd_eO-VigUqY11-d-cej-8lBQK6oVFfUV5ajFET_rH_AsPhvG7lfGAwu2G01y9Bw6DhGVwjnjBN3SBBdZ_xGZxE2oq6UXWbBmzKB9I0LJNEa8asFnrcyHR8UPewN98f7poluw9HM_48eH_aMNWEYdRKYC8gMsTOqp-ohQaJJvapP_C68w_Qk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mouse+and+human+FcR+effector+functions&rft.jtitle=Immunological+reviews&rft.au=Bruhns%2C+Pierre&rft.au=J%C3%B6nsson%2C+Friederike&rft.date=2015-11-01&rft.issn=0105-2896&rft.eissn=1600-065X&rft.volume=268&rft.issue=1&rft.spage=25&rft.epage=51&rft_id=info:doi/10.1111%2Fimr.12350&rft.externalDBID=10.1111%252Fimr.12350&rft.externalDocID=IMR12350 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-2896&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-2896&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-2896&client=summon |